<!DOCTYPE html><html lang="en"><head><script src="https://cdnjs.cloudflare.com/ajax/libs/js-polyfills/0.1.42/polyfill.min.js"></script><link href="https://www.hindawi.com/static/themes/hindawi/base.css" rel="stylesheet"/><meta charSet="utf-8" class="next-head"/><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"/><title class="next-head">Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes</title><link rel="canonical" href="https://www.hindawi.com/journals/ecam/2013/938081/" class="next-head"/><link rel="shortcut icon" type="image/x-icon" href="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico" class="next-head"/><meta name="title" content="Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"/><meta rel="canonical" href="https://www.hindawi.com/journals/ecam/2013/938081/"/><meta name="description" content="Stevioside from &lt;i  &gt;Stevia rebaudiana&lt;/i&gt; has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects &lt;i  &gt;in vitro&lt;/i&gt;. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17&amp;#x25;, making it impossible to determine its IC&lt;sub  &gt;50&lt;/sub&gt;. Stevioside increased glucose uptake activities by 2.1 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M1&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;path id=&quot;x1D45D&quot; d=&quot;M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&amp;#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;path id=&quot;x3C&quot; d=&quot;M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;path id=&quot;x30&quot; d=&quot;M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&amp;#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;path id=&quot;x2E&quot; d=&quot;M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;path id=&quot;x31&quot; d=&quot;M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z&quot; /&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in normal conditions and up to 4.4 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M2&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x1D45D&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x3C&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x2E&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x31&quot;/&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."/><meta property="og:url" content="https://www.hindawi.com/journals/ecam/2013/938081/"/><meta property="og:type" content="website"/><meta property="og:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta property="og:image:type" content="image/jpeg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="315"/><meta property="og:title" content="Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"/><meta name="twitter:site" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta name="twitter:title" content="Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"/><meta property="og:description" content="Stevioside from &lt;i  &gt;Stevia rebaudiana&lt;/i&gt; has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects &lt;i  &gt;in vitro&lt;/i&gt;. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17&amp;#x25;, making it impossible to determine its IC&lt;sub  &gt;50&lt;/sub&gt;. Stevioside increased glucose uptake activities by 2.1 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M1&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;path id=&quot;x1D45D&quot; d=&quot;M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&amp;#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;path id=&quot;x3C&quot; d=&quot;M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;path id=&quot;x30&quot; d=&quot;M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&amp;#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;path id=&quot;x2E&quot; d=&quot;M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;path id=&quot;x31&quot; d=&quot;M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z&quot; /&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in normal conditions and up to 4.4 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M2&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x1D45D&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x3C&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x2E&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x31&quot;/&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."/><meta name="twitter:description" content="Stevioside from &lt;i  &gt;Stevia rebaudiana&lt;/i&gt; has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects &lt;i  &gt;in vitro&lt;/i&gt;. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17&amp;#x25;, making it impossible to determine its IC&lt;sub  &gt;50&lt;/sub&gt;. Stevioside increased glucose uptake activities by 2.1 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M1&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;path id=&quot;x1D45D&quot; d=&quot;M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&amp;#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;path id=&quot;x3C&quot; d=&quot;M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;path id=&quot;x30&quot; d=&quot;M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&amp;#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;path id=&quot;x2E&quot; d=&quot;M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;path id=&quot;x31&quot; d=&quot;M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z&quot; /&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in normal conditions and up to 4.4 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M2&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x1D45D&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x3C&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x2E&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x31&quot;/&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."/><meta name="citation_title" content="Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"/><meta name="citation_author" content="Mohd-Radzman, Nabilatul Hani"/><meta name="citation_author" content="Ismail, Wan Iryani Wan"/><meta name="citation_author" content="Jaapar, Siti Safura"/><meta name="citation_author" content="Adam, Zainah"/><meta name="citation_author" content="Adam, Aishah"/><meta name="citation_journal_title" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="citation_publisher" content="Hindawi"/><meta name="citation_volume" content="2013"/><meta name="citation_year" content="2013"/><meta name="citation_date" content="2013/12/11"/><meta name="citation_online_date" content="2013/12/11"/><meta name="citation_doi" content="https://doi.org/10.1155/2013/938081"/><meta name="citation_issn" content="1741-427X"/><meta name="citation_abstract" content="Stevioside from &lt;i  &gt;Stevia rebaudiana&lt;/i&gt; has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects &lt;i  &gt;in vitro&lt;/i&gt;. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17&amp;#x25;, making it impossible to determine its IC&lt;sub  &gt;50&lt;/sub&gt;. Stevioside increased glucose uptake activities by 2.1 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M1&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;path id=&quot;x1D45D&quot; d=&quot;M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&amp;#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;path id=&quot;x3C&quot; d=&quot;M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;path id=&quot;x30&quot; d=&quot;M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&amp;#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;path id=&quot;x2E&quot; d=&quot;M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;path id=&quot;x31&quot; d=&quot;M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z&quot; /&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in normal conditions and up to 4.4 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M2&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x1D45D&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x3C&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x2E&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x31&quot;/&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."/><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/ecam/2013/938081/"/><meta name="citation_pdf_url" content="https://downloads.hindawi.com/journals/ecam/2013/938081.pdf"/><meta name="citation_xml_url" content="https://downloads.hindawi.com/journals/ecam/2013/938081.xml"/><meta name="dc.creator" content="Mohd-Radzman, Nabilatul Hani"/><meta name="dc.creator" content="Ismail, Wan Iryani Wan"/><meta name="dc.creator" content="Jaapar, Siti Safura"/><meta name="dc.creator" content="Adam, Zainah"/><meta name="dc.creator" content="Adam, Aishah"/><meta name="dc.title" content="Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"/><meta name="dc.description" content="Stevioside from &lt;i  &gt;Stevia rebaudiana&lt;/i&gt; has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects &lt;i  &gt;in vitro&lt;/i&gt;. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17&amp;#x25;, making it impossible to determine its IC&lt;sub  &gt;50&lt;/sub&gt;. Stevioside increased glucose uptake activities by 2.1 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M1&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;path id=&quot;x1D45D&quot; d=&quot;M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&amp;#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;path id=&quot;x3C&quot; d=&quot;M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;path id=&quot;x30&quot; d=&quot;M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&amp;#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;path id=&quot;x2E&quot; d=&quot;M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z&quot; /&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;path id=&quot;x31&quot; d=&quot;M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z&quot; /&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in normal conditions and up to 4.4 times (&lt;svg     style=&quot;vertical-align:-3.50804pt;width:66.137497px;&quot; id=&quot;M2&quot; height=&quot;15.2875&quot; version=&quot;1.1&quot; viewBox=&quot;0 0 66.137497 15.2875&quot; width=&quot;66.137497&quot;  xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; xmlns=&quot;http://www.w3.org/2000/svg&quot;&gt;
	
		
			&lt;g transform=&quot;matrix(.017,-0,0,-.017,.062,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x1D45D&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,14.851,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x3C&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,29.555,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,37.715,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x2E&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,41.59,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,49.75,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x30&quot;/&gt;&lt;/g&gt;&lt;g transform=&quot;matrix(.017,-0,0,-.017,57.909,10.862)&quot;&gt;&lt;use xlink:href=&quot;#x31&quot;/&gt;&lt;/g&gt;

		
	
&lt;/svg&gt;) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."/><meta name="dc.publisher" content="Hindawi"/><meta name="dc.format" content="text/html"/><meta name="dc.language" content="en"/><meta name="dc.identifier" content="https://doi.org/10.1155/2013/938081"/><meta name="dc.type" content="Research Article"/><meta name="dc.date" content="2013/12/11"/><meta name="dcterms.issued" content="2013/12/11"/><meta name="prism.publicationDate" content="2013/12/11"/><meta name="prism.volume" content="2013"/><meta name="prism.section" content="Research Article"/><meta name="prism.doi" content="https://doi.org/10.1155/2013/938081"/><meta name="prism.issn" content="1741-427X"/><meta name="dc.source" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="prism.publicationName" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="authors" content="Nabilatul Hani Mohd-Radzman | Wan Iryani Wan Ismail | ... | Aishah Adam"/><meta name="Author" content="Hindawi"/><meta name="robots" content="index"/><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"/><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="fbafd62a-0a4e-4f7b-a04d-56f57fa3d716"></script><link href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/basictable.css" rel="stylesheet" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.carousel.min.css" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.theme.default.min.css" media="none" class="next-head"/><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/jquery.js" class="next-head"></script><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" as="script"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/common.19957fe3.chunk.css"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js.bf2397b9.chunk.css"/><style data-styled="NQpXC gnduKR jzXSTA bNmdOy epRoim bUhGXt gjctdt jGJLow kAzjOl ivbKJD fopjOz hbVEoI khbeDd gvAGTV kNoiZu diutvq bqeMOy bMdQcY ldSkVQ cmzomn fJLQxX kuxTps prcY bJcSpM elhyhe fTkdCR jCfZqq EwsTm mkXor dULvrJ dfaOeH jOLhQl TsaZF iiusBg cqhPZs gaRePw dEfJbW eBepOs fSPaCp bVEEaH etauus ctePXh gCIfTO OGgkt dUABlg jUTgTa eujois cQgXqt ewCAZX kdvWPs hAFFGk lkWWFY ehYbwJ legory epgILe kCfRMJ bjwAQR byflLi jXeALb UVThf dDyxFF fkVFlF dzZrgS jLUVhb dVCLgr bBmZJZ ewHMLz bbzREB jknsZc eSvjPB jntdRu iySbrx bCmGAV TdHTO bmMPie fClRDD iomKnj fexZtq eGVCps mBGSe fgGykB gQxyld bVtmCk hSHJbi ktFfKO bkiEfx ztvYg cUsFHx duuwge lcOiDF gsmOCv kPshFw kRoxOt jZOxOO eHMFfo XkrFe irNWJI dMuGGA kfDwZY evMkvU fYrLtk fjviok hgKieC cIribm khHUcu exFqMv dbAANp eyHfWh cBTaXT becpDt kbSZJl jzTMLK gbrQxi hRnXob hymroZ cbcyj hmDWcT isgRZA ihmyEq itFKcQ cGuwDn jrsDZP gWTCXQ jGPvPL etzuBr gWgCNb WHkfb ibWUzs kdRRST cHatnS kxdGAZ jHPgUP fXBKFa hNPrIr bnbfTS cYsVdk inBNwS dkutRV hlGpbO filPdg ecHxGW gCiATD eEFYIL dsXEHZ iXKuYd" data-styled-version="4.4.1">
/* sc-component-id: sc-bdVaJa */
.EwsTm{height:200vh;width:100%;position:fixed;z-index:1;background:rgba(255,255,255,0.8);} .EwsTm.isHide{display:none;} @media (min-width:768px) and (max-width:991px){} @media (min-width:992px){.EwsTm{display:none;}}
/* sc-component-id: sc-htpNat */
.bUhGXt{color:black;-webkit-text-decoration:none;text-decoration:none;border-radius:5px;font-size:16px;} .bUhGXt:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-bxivhb */
.ivbKJD{display:inline-block;}
/* sc-component-id: sc-ifAKCX */
.fopjOz{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;padding:0;} .fopjOz li{padding:0 10px;} .fopjOz li a{padding:0;} .fopjOz a{-webkit-transition:border .25s ease-in-out 0s;transition:border .25s ease-in-out 0s;border-bottom:2px solid #fff;border-radius:0;} .fopjOz a:hover{border-bottom:2px solid #9b9b9b;padding-bottom:4px;} .fopjOz .active{border-bottom:2px solid #57a61e;}
/* sc-component-id: sc-EHOje */
.jOLhQl{vertical-align:middle;height:24px;}.TsaZF{vertical-align:middle;height:40px;}.iiusBg{vertical-align:middle;height:16px;}
/* sc-component-id: sc-bZQynM */
.bNmdOy{max-width:1440px;margin:0 auto;width:100%;}
/* sc-component-id: sc-htoDjs */
.khbeDd{vertical-align:middle;font-size:24px;}.gvAGTV{vertical-align:middle;font-size:9px;}.kNoiZu{vertical-align:middle;font-size:16px;}.diutvq{vertical-align:middle;font-size:22px;}.bqeMOy{vertical-align:middle;font-size:20px;}.bMdQcY{vertical-align:middle;font-size:11px;}
/* sc-component-id: sc-fjdhpX */
.jzXSTA{position:fixed;top:0;left:0;right:0;z-index:1000;background:#fff;height:70px;font-size:16px;font-weight:500;border-bottom:1px solid #e3e3e3;-webkit-transition:all 0.5s;transition:all 0.5s;} @media (max-width:991px){.jzXSTA{border-bottom:1px solid #e3e3e3;}} @media (max-width:767px){.jzXSTA{margin-bottom:70px;height:60px;}} .jzXSTA .header__padding{padding:0 20px;box-sizing:border-box;} @media (max-width:991px){.jzXSTA .header__padding{padding:0 0 0 20px;}} .jzXSTA .menu{position:fixed;top:60px;right:0;width:100%;background:white;} @media (max-width:991px){.jzXSTA .menu{z-index:2;}} @media (min-width:768px){.jzXSTA .menu{width:500px;top:70px;}} @media (min-width:991.5px){.jzXSTA .menu{display:none;}} .jzXSTA .menu ul{list-style-type:none;text-align:center;padding:0;margin:0;} @media (min-width:768px){.jzXSTA .menu ul{padding:0;border-left:1px solid #e3e3e3;}} .jzXSTA .menu ul li a{color:#4a4a4a;padding:10px;-webkit-text-decoration:none;text-decoration:none;display:block;border-bottom:1px solid #e3e3e3;} .jzXSTA .menu .button_wrap{width:90%;margin:10px auto;border-radius:5px;border-style:solid;border-width:1px;} @media (min-width:768px){.jzXSTA .menu .button_wrap{display:none;}} .jzXSTA .menu .button__publishing{background-color:#6ba439;color:#fff;border-color:#6ba439;} .jzXSTA .menu .button__login{display:none;background-color:#fff;color:#4D8A17;border-color:#e3e3e3;} .jzXSTA.headerUp{-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);}
/* sc-component-id: sc-jzJRlG */
.jGJLow{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .jGJLow a{padding:10px;} .jGJLow nav{-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} @media (max-width:991px){.jGJLow nav{display:none;}} .jGJLow nav ul{margin-right:16px;} .jGJLow nav ul li a{color:#4a4a4a;padding:10px 0px 4px;margin:0 6px;} @media (max-width:991px){.jGJLow .icon-themeable{border-left:1px solid #e3e3e3;padding:23px 20px;}} @media (max-width:767px){.jGJLow .icon-themeable{padding:18px 20px;}} @media (max-width:767.5px){.jGJLow.mobileButtonFlex{-ms-flex:0 0 51%;-webkit-flex:0 0 51%;-ms-flex:0 0 51%;flex:0 0 51%;max-width:51%;}}
/* sc-component-id: sc-cSHVUG */
.ldSkVQ{display:none;padding:0;background-color:#fff;border:none;height:59px;} @media (min-width:768px){.ldSkVQ{height:69px;}} .ldSkVQ img{box-sizing:content-box;width:28px;padding:17px 20px;} @media (min-width:768px){.ldSkVQ img{padding:22px 20px;}} @media (max-width:991px){.ldSkVQ{display:inline-block;}}
/* sc-component-id: sc-kAzzGY */
.epRoim a{display:inline-block;padding:15px 0;} @media (max-width:767px){.epRoim a{padding:10px 0;}} @media (max-width:767.5px){.epRoim.mobileLogoFlex{-ms-flex:0 0 49%;-webkit-flex:0 0 49%;-ms-flex:0 0 49%;flex:0 0 49%;max-width:49%;}}
/* sc-component-id: sc-chPdSV */
.hbVEoI{border:none;height:50px;background-color:#fff;margin:10px 0 0 17px;position:relative;} @media (max-width:991.5px){.hbVEoI{margin:0 3px 0 16px;padding:0;height:69px;}} @media (max-width:767.5px){.hbVEoI{height:59px;}} .hbVEoI img{box-sizing:content-box;} .hbVEoI .icon__cross{width:24px;height:24px;} @media (min-width:768px){.hbVEoI .icon__cross{padding:23px 20px;}} @media (min-width:992px){.hbVEoI .icon__cross{padding:0px;}}
/* sc-component-id: sc-ckVGcZ */
.gjctdt{vertical-align:middle;height:39px;} @media (max-width:401px){.gjctdt{max-width:100%;}}
/* sc-component-id: sc-jKJlTe */
.inBNwS{background-color:#0d2934;font-size:16px;position:relative;z-index:3;} @media (max-width:991px){.inBNwS{z-index:0;}}
/* sc-component-id: sc-eNQAEJ */
.dkutRV{border-bottom :1px solid;border-color:#828282;padding:29px 40px 30px 40px;} @media (min-width:992px){.dkutRV{padding:40px 40px 40px 35px;}} .dkutRV .primary__footer .mobile{display:block;} .dkutRV .primary__footer .desktop{display:none;} @media (min-width:992px){.dkutRV .primary__footer{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;}.dkutRV .primary__footer .mobile{display:none;}.dkutRV .primary__footer .desktop{display:block;}} @media (min-width:992px){.dkutRV .col5{-webkit-flex:0 0 18%;-ms-flex:0 0 18%;flex:0 0 18%;max-width:18%;}} .dkutRV address{font-style:inherit;line-height:1.5;font-size:16px;display:none;border-right:1px solid #EBEBEB;} @media (max-width:767px){.dkutRV address{border-bottom:1px solid #E3E3E3;padding-bottom:20px;}} @media (min-width:992px){.dkutRV address{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin-right:50px;}} @media (min-width:1200px){.dkutRV address{margin-right:70px;}} .dkutRV address p{margin:0;font-size:14px;} @media (max-width:767px){.dkutRV address p{text-align:center;}} @media (min-width:1200px){.dkutRV address p{font-size:16px;}} .dkutRV nav ul{list-style:none;padding:0;line-height:2;font-size:16px;margin:18px 0 0 0;} .dkutRV nav ul:first-child{margin:0;} @media (min-width:992px){.dkutRV nav ul{margin:0;}} .dkutRV nav ul li{line-height:22px;padding:5px;} .dkutRV nav ul li a{color:#d8d8d8;font-weight:500;display:block;font-size:16px;} .dkutRV nav ul li img{padding:2.5px 0 0 10px;box-sizing:content-box;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-hMqMXs */
.hlGpbO{padding-top:6px;color:#FFFFFF;font-weight:500;margin-bottom:29px;} @media (min-width:992px){.hlGpbO{-webkit-flex:0 0 25%;-ms-flex:0 0 25%;flex:0 0 25%;max-width:-webkit-fit-content;max-width:-moz-fit-content;max-width:fit-content;}}
/* sc-component-id: sc-kEYyzF */
.ecHxGW{margin-right:20px;} .ecHxGW:last-child{margin-right:0;}
/* sc-component-id: sc-kkGfuU */
.filPdg{margin-top:15px;}
/* sc-component-id: sc-iAyFgw */
.gCiATD{line-height:30px;font-size:11px;padding:10px 20px;text-align:center;} .gCiATD .textright{text-align:right;font-weight:500;} @media (max-width:767px){.gCiATD .textright{text-align:center;}} @media (min-width:992px){.gCiATD .textright{font-weight:100;}} .gCiATD a{font-size:13px;color:#fff;}
/* sc-component-id: sc-hSdWYo */
.etauus{display:inline-block;background-color:#fff;color:#4D8A17;border-color:#E3E3E3;width:auto;border-radius:5px;font-size:16px;border-width:1px;border-style:solid;} .etauus:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-eHgmQL */
.fTkdCR{font-size:22px;color:#000;} @media (min-width:767.5px){.fTkdCR{font-size:24px;}} @media (min-width:991.5px){.fTkdCR{font-size:25px;}} .fTkdCR:after{content:'';display:inline-block;margin-top:0.2em;margin-left:0.5em;}
/* sc-component-id: sc-iRbamj */
.jZOxOO{font-size:30px;font-weight:500;-webkit-letter-spacing:1px;-moz-letter-spacing:1px;-ms-letter-spacing:1px;letter-spacing:1px;line-height:1;margin-top:0;} @media (min-width:767.5px){.jZOxOO{font-size:40px;}} @media (min-width:991.5px){.jZOxOO{font-size:40px;}} .jZOxOO sup,.jZOxOO sub{vertical-align:baseline;position:relative;top:-10px;} .jZOxOO sub{top:10px;}
/* sc-component-id: sc-Rmtcm */
.hNPrIr{font-size:20px;font-weight:500;margin-top:0;margin-bottom:15px;}
/* sc-component-id: sc-bRBYWo */
.fXBKFa{display:inline-block;} @media (max-width:991.5px){.fXBKFa{width:100%;}} @media (min-width:991.5px){.fXBKFa.hide{display:none !important;}}
/* sc-component-id: sc-hzDkRC */
.bnbfTS{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;width:100%;padding:0 !important;border-top:1px solid #fff;} .bnbfTS li{width:100%;text-align:center;box-sizing:border-box;padding:17px 0px;min-height:48px;} .bnbfTS li a{display:block;} .bnbfTS .iconBorder{border-right:1px solid #fff;} .bnbfTS img{width:23px;} .bnbfTS img.socialLinkedin{width:28px;} .bnbfTS .wechat-container{position:relative;} .bnbfTS .wechat-container .addthis_inline_share_toolbox{position:absolute;top:0;left:0;width:100%;height:100%;opacity:0 !important;}
/* sc-component-id: sc-jtRfpW */
.OGgkt{background-color:#6BA439;color:#fff;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #fff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .OGgkt img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.OGgkt span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.OGgkt span.text{padding-left:20px;}}.dUABlg{background-color:#F2F2F2;color:#4A4A4A;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #E3E3E3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .dUABlg img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.dUABlg span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.dUABlg span.text{padding-left:20px;}}
/* sc-component-id: sc-kTUwUJ */
.eujois{width:20px;}
/* sc-component-id: sc-dqBHgY */
.cQgXqt{width:20px;height:16px;color:#6ba439;}
/* sc-component-id: sc-cbkKFq */
.kuxTps{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;position:fixed;top:60px;} @media (min-width:767.5px){.kuxTps{position:fixed;top:70px;}} @media (min-width:991.5px){.kuxTps{position:fixed;top:70px;}}.prcY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;top:0px;} @media (min-width:767.5px){.prcY{top:0px;}} @media (min-width:991.5px){.prcY{position:fixed;top:241px;}}
/* sc-component-id: sc-hGoxap */
.dEfJbW{position:relative;background:#007d8d;} @media (max-width:991px){.dEfJbW{z-index:2;}} @media (min-width:767.5px) and (max-width:991.5px){.dEfJbW{width:50%;}} @media (min-width:991.5px){.dEfJbW{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:1px solid white;}} .dEfJbW.isHide{display:none;} @media (min-width:991.5px){.dEfJbW.isHide{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .dEfJbW .submit__button{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;box-shadow:0 2px 4px rgba(0,0,0,.5);padding:0 20px;min-height:45px;} .dEfJbW .submit__button span.text{font-size:16px;} .dEfJbW .submit__button img{width:20px;} @media (min-width:767.5px){.dEfJbW .submit__button{min-height:58px;}.dEfJbW .submit__button img{width:22px;}} @media (min-width:991.5px){.dEfJbW .submit__button{display:none;}}
/* sc-component-id: sc-fjmCvl */
.fSPaCp{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.fSPaCp{padding:16px 20px;}} @media (min-width:991.5px){.fSPaCp{border-top:none;border-right:1px solid #fff;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.fSPaCp{padding:14.5px 20px;font-size:16px;}} .fSPaCp .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .fSPaCp.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.fSPaCp.button__active{border-right:1px solid #007f8f;}} .fSPaCp .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .fSPaCp .icon__hidden{display:none;}.bVEEaH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.bVEEaH{padding:16px 20px;}} @media (min-width:991.5px){.bVEEaH{border-top:none;border-right:0;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.bVEEaH{padding:14.5px 20px;font-size:16px;}} .bVEEaH .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .bVEEaH.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.bVEEaH.button__active{border-right:1px solid #007f8f;}} .bVEEaH .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .bVEEaH .icon__hidden{display:none;}
/* sc-component-id: sc-TFwJa */
.gCIfTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:767.5px){.gCIfTO{padding:16px 20px;}} @media (min-width:991.5px){.gCIfTO{-webkit-transition:all 0.25s;transition:all 0.25s;border-top:none;border-right:1px solid #fff;border-left:0;padding:14.5px 30px 14.5px 20px;width:calc(100% / 6);font-size:14px;}.gCIfTO:hover{background:#fff;color:#4A4A4A;}} @media (min-width:1200px){.gCIfTO{font-size:16px;}}
/* sc-component-id: sc-bHwgHz */
.ctePXh{width:18px;margin-right:-4px;} @media (min-width:991.5px){.ctePXh{width:7px;font-size:7px;}} @media (min-width:1200px){.ctePXh{width:18px;}}
/* sc-component-id: sc-krDsej */
.ewCAZX{position:absolute;top:0;width:calc(100% - 20px);right:0;bottom:0;background:#fff;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;min-height:290px;box-shadow:0 2px 4px rgba(0,0,0,0.5);} .ewCAZX.hide__submenu{-webkit-transform:translateX(100%);-ms-transform:translateX(100%);transform:translateX(100%);} @media (min-width:767.5px){.ewCAZX.hide__submenu{-webkit-transform:translateX(-200%);-ms-transform:translateX(-200%);transform:translateX(-200%);}} @media (min-width:767.5px){.ewCAZX{left:100%;width:100%;padding-top:20px;z-index:-1;min-height:375px;}} @media (min-width:991.5px){.ewCAZX{display:none;}}
/* sc-component-id: sc-dTdPqK */
.lkWWFY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;display:none;} @media (min-width:991.5px){.lkWWFY.hide__submenu{-webkit-transform:translateY(-300%);-ms-transform:translateY(-300%);transform:translateY(-300%);}} @media (min-width:991.5px){.lkWWFY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:186px;top:49px;left:0;position:absolute;right:0;background:#fff;z-index:-1;box-shadow:0 4px 6px rgba(0,0,0,0.21);}}
/* sc-component-id: sc-itybZL */
.kdvWPs{font-weight:700;border:0;color:#4A4A4A;padding:10px 0;background-color:#fff;font-size:16px;line-height:20px;} .kdvWPs:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;} @media (min-width:767.5px){.kdvWPs{display:none;}}
/* sc-component-id: sc-fzsDOv */
.hAFFGk{margin:0px 10px 2px 20px;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);display:inline-block;}
/* sc-component-id: sc-gPWkxV */
.legory{width:50%;}
/* sc-component-id: sc-jVODtj */
.epgILe{color:#007B8B;width:50%;font-size:16px;line-height:26px;margin:auto;padding:0 6%;}
/* sc-component-id: sc-kUaPvJ */
.ehYbwJ{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:50%;padding:24.5px 2% 0;-webkit-order:0;-ms-flex-order:0;order:0;} @media (min-width:1024px){.ehYbwJ{padding:24.5px 3% 0;}}
/* sc-component-id: sc-giadOv */
.eBepOs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} @media (min-width:991.5px){.eBepOs{width:calc(100% / 6);}.eBepOs:first-child{border-left:none;}}
/* sc-component-id: sc-fONwsr */
.kCfRMJ{background-color:#D8D8D8;position:absolute;left:50%;display:inline-block;height:121px;width:2px;top:33px;}
/* sc-component-id: sc-LKuAh */
.lcOiDF{padding:0;margin:10px 0 25px 0;}
/* sc-component-id: sc-iBEsjs */
.kPshFw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kPshFw:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kPshFw{margin-top:10px;}}
/* sc-component-id: sc-hzNEM */
.gsmOCv{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;background-color:#F2F2F2;padding:0 16px;} .gsmOCv.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .gsmOCv p{font-size:14px;line-height:22px;} .gsmOCv sup{margin-top:-5px;}
/* sc-component-id: sc-chbbiW */
.mBGSe{padding:0;}
/* sc-component-id: sc-kxynE */
.fgGykB{margin-top:30px;} @media (min-width:991.5px){.fgGykB{margin-top:0;}}
/* sc-component-id: sc-cooIXK */
.gQxyld{background:#FF9014;color:white;font-size:14px;font-weight:bold;padding:5px;}
/* sc-component-id: sc-fcdeBU */
.bVtmCk{font-size:14px;margin:15px 0 5px;} @media (min-width:768px){.bVtmCk{font-size:14px;}} @media (min-width:992px){.bVtmCk{font-size:20px;}}
/* sc-component-id: sc-gmeYpB */
.hSHJbi{font-size:12px;}
/* sc-component-id: sc-kZmsYB */
.bkiEfx{font-size:14px;font-weight:700;line-height:16px;-webkit-letter-spacing:0.58px;-moz-letter-spacing:0.58px;-ms-letter-spacing:0.58px;letter-spacing:0.58px;margin:23px 0 0px !important;} @media (min-width:767.5px){.bkiEfx{margin:34px 0 0px !important;}} @media (min-width:991.5px){.bkiEfx{margin:-4px 0 0 !important;}}
/* sc-component-id: sc-RcBXQ */
.ztvYg{font-size:14px;line-height:22px;} .ztvYg a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .ztvYg a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-iSDuPN */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Bold.otf');font-weight:normal;font-style:normal;} .kRoxOt{font-weight:700;font-family:STIXGeneral-Bold;margin:19px 0 22px;font-size:25px;line-height:28px;-webkit-letter-spacing:normal;-moz-letter-spacing:normal;-ms-letter-spacing:normal;letter-spacing:normal;} @media (min-width:767.5px){.kRoxOt{font-size:25px;margin:20px 0 23px;}} @media (min-width:991.5px){.kRoxOt{font-size:30px;line-height:34px;margin:19px 0 22px;}} .kRoxOt p{margin:0;}
/* sc-component-id: sc-fZwumE */
.cUsFHx{padding:0 3px;}
/* sc-component-id: sc-fQejPQ */
.duuwge{font-size:14px;} .duuwge:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-clNaTc */
.ktFfKO{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;}
/* sc-component-id: sc-jtRlXQ */
@font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} .exFqMv{font-family:STIXGeneral-Regular;text-align:justify;} .exFqMv a{word-break:break-all;} .exFqMv h4:first-of-type{border-top:0px solid #E3E3E3;padding-top:0;} .exFqMv h4{font-size:20px;font-family:"IBM Plex Sans",sans-serif;border-top:1px solid #E3E3E3;padding-top:23px;margin-top:15px;margin-bottom:-3px;} .exFqMv h4#abstract{margin-top:-7px;margin-bottom:-3px;} @media (min-width:767.5){.exFqMv h4#abstract{margin-top:-6px;}} @media (min-width:991.5px){.exFqMv h4#abstract{margin-top:34px;}} .exFqMv h4.references,.exFqMv h4.copyright{border-top:1px solid #E3E3E3;padding-top:23px;} .exFqMv h4.references{margin-bottom:-8px;} .exFqMv h5,.exFqMv h6{margin:22px 0;font-size:16px;word-break:break-word;} .exFqMv h6{margin:25px 0;text-align:left;} .exFqMv p{font-size:16px;word-break:break-word;} .exFqMv .floats-partial-section{border:1px solid #E3E3E3;margin:25px auto;} @media (max-width:767px){.exFqMv .floats-partial-section{margin:0 auto;overflow-x:hidden;}} .exFqMv .floats-partial-section .floats-partial-content{padding:19px 0px 19px 0px;height:254px;width:96%;overflow:hidden;margin:0 auto;position:relative;cursor:pointer;} .exFqMv .floats-partial-section .floats-partial-content table{margin:0 auto;} .exFqMv .floats-partial-section .floats-partial-content .table-group{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table object{z-index:-1;position:relative;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td{padding:4px 7px;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_left{text-align:left;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_center{text-align:center;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-content{padding:22px 0px 0 0px;height:197px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-content{padding:23px 0px 13px 0px;height:215px;}} .exFqMv .floats-partial-section .floats-partial-content:after{content:"";height:20%;position:absolute;bottom:0;right:0;left:0;background:-moz-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-webkit-gradient(linear,left top,right top,color-stop(0%,rgba(255,255,255,.7)),color-stop(56%,rgba(255,255,255,.7)),color-stop(100%,rgba(255,255,255,.7)));background:-webkit-linear-gradient(rgba(255,255,255,0) 0%,rgba(255,255,255,0.5) 30%,rgba(255,255,255,0.7) 56%,rgba(255,255,255,0.9) 75%,rgba(255,255,255,1) 100%);background:-o-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-ms-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);-webkit-filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );} .exFqMv .floats-partial-section .floats-partial-footer{background-color:#F2F2F2;border-top:1px solid #E3E3E3;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMTZweCIgaGVpZ2h0PSIycHgiIHZpZXdCb3g9IjAgMCAxNiAyIiB2ZXJzaW9uPSIxLjEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiPgogICAgPCEtLSBHZW5lcmF0b3I6IFNrZXRjaCA1My4yICg3MjY0MykgLSBodHRwczovL3NrZXRjaGFwcC5jb20gLS0+CiAgICA8dGl0bGU+SWNvbnMvQ2xvc2UgTWVudSAtPC90aXRsZT4KICAgIDxkZXNjPkNyZWF0ZWQgd2l0aCBTa2V0Y2guPC9kZXNjPgogICAgPGRlZnM+CiAgICAgICAgPHBhdGggZD0iTTUsMTMgTDE5LDEzIEMxOS41NTIyODQ3LDEzIDIwLDEyLjU1MjI4NDcgMjAsMTIgQzIwLDExLjQ0NzcxNTMgMTkuNTUyMjg0NywxMSAxOSwxMSBMNSwxMSBDNC40NDc3MTUyNSwxMSA0LDExLjQ0NzcxNTMgNCwxMiBDNCwxMi41NTIyODQ3IDQuNDQ3NzE1MjUsMTMgNSwxMyBaIiBpZD0icGF0aC0xIj48L3BhdGg+CiAgICA8L2RlZnM+CiAgICA8ZyBpZD0iUGFnZS0xIiBzdHJva2U9Im5vbmUiIHN0cm9rZS13aWR0aD0iMSIgZmlsbD0ibm9uZSIgZmlsbC1ydWxlPSJldmVub2RkIj4KICAgICAgICA8ZyBpZD0iQXJ0aWNsZS0tLU1vYmlsZS0tLUFsZ29yaXRobSIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTIwLjAwMDAwMCwgLTU0MS4wMDAwMDApIj4KICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjU3LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwLTkiPgogICAgICAgICAgICAgICAgICAgIDxnIGlkPSJHcm91cC04IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjUyLjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iR3JvdXAtNyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMC4wMDAwMDAsIDIuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iSWNvbnMvQ2xvc2UtTWVudS0tIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMy4wMDAwMDAsIDE2LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJtaW51cyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMy4wMDAwMDAsIDMuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxtYXNrIGlkPSJtYXNrLTIiIGZpbGw9IndoaXRlIj4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvbWFzaz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHVzZSBpZD0iU2hhcGUiIGZpbGw9IiMwMDAwMDAiIGZpbGwtcnVsZT0ibm9uemVybyIgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJDT0xPUi8tUHJpbWFyeS1HcmVlbiIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjNkJBNDM5IiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHJlY3QgaWQ9IlJlY3RhbmdsZSIgeD0iMCIgeT0iMCIgd2lkdGg9IjI0IiBoZWlnaHQ9IjI0Ij48L3JlY3Q+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgIDwvZz4KICAgICAgICA8L2c+CiAgICA8L2c+Cjwvc3ZnPg==') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;display:none;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{-webkit-flex:9;-ms-flex:9;flex:9;text-align:left;padding:21px 37px 10px 0px;font-size:16px;font-weight:700;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 18px 10px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 21px 10px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;padding:16px 0 16px 0;min-width:62px;max-width:62px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:16px 0 17px 0;min-width:52px;max-width:52px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:15px 0 17px 0;min-width:60px;max-width:60px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url:hover{-webkit-text-decoration:none;text-decoration:none;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{font-size:14px;padding:0px 18px 17px 22px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 15px 15px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 18px 19px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text figcaption{margin:0;padding:0;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text svg{max-width:100%;} .exFqMv ol{font-size:16px;padding-left:32px;font-family:STIXGeneral-Regular;line-height:24px;margin:15px 0;} .exFqMv ol li{margin:10px 0;padding-left:10px;word-break:normal;} .exFqMv ol li a{word-break:break-all;} .exFqMv ol li .reflinks{display:block;} .exFqMv ol li .reflinks a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .exFqMv ol li .reflinks a:hover{-webkit-text-decoration:underline;text-decoration:underline;} .exFqMv ol li .reflinks .sep{color:#000000;} .exFqMv .table-wrapper{width:auto;overflow-x:auto;} .exFqMv .table-wrapper::-webkit-scrollbar{-webkit-appearance:none;width:5px;height:5px;} .exFqMv .table-wrapper::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(0,0,0,.5);-webkit-box-shadow:0 0 1px rgba(255,255,255,.5);} @media (min-width:768px){.exFqMv .table-wrapper{overflow-x:auto;width:auto;-webkit-break-word:word-break;break-word:word-break;margin:0 auto;}} @media (min-width:992px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:1324px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:320px){.exFqMv{margin-bottom:33px;padding:0;}} @media (min-width:992px){.exFqMv{padding:0;margin-bottom:100px;}} @media (min-width:1325px){.exFqMv{margin-bottom:100px;}} .exFqMv .owl-stage{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot svg{fill:#4D8A17;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot strong{color:#4D8A17;font-weight:500;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active strong{color:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active svg{fill:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot .nowrap{white-space:nowrap;} .exFqMv .partial-carousel-dot{text-align:center;cursor:pointer;border:0;width:100px;padding-bottom:20px;background-color:#fff;display:table-cell;} .exFqMv .partial-carousel-dot:focus-visible{outline-offset:-3px;} .exFqMv .partial-carousel-dot strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel-dot strong{font-size:16px;}} .exFqMv .partial-carousel-dot img{width:90px;height:90px;border:1px solid #979797;margin:10px 0;} .exFqMv .partial-carousel-wrapper .floats-partial-middle{border-top:1px solid #e3e3e3;display:block;margin-bottom:50px;padding-top:1px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:0;}} .exFqMv .partial-carousel--single-image{overflow:hidden;text-align:center;} .exFqMv .partial-carousel--single-image img{width:100%;max-height:239px;height:auto;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image img{max-height:357px;}} @media (min-width:991.5px){.exFqMv .partial-carousel--single-image img{max-height:417px;}} .exFqMv .partial-carousel--single-image strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image strong{font-size:16px;}} .exFqMv .owl-nav,.exFqMv .owl-dots{display:none;} .exFqMv .partial-carousel-wrapper .owl-loaded{position:relative;height:auto;max-height:287px;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:287px;height:auto;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content::after,.exFqMv .owl-stage-outer::after,.exFqMv .owl-stage::after{background:transparent;} .exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:100%;overflow-x:auto;-webkit-align-items:self-start;-webkit-box-align:self-start;-ms-flex-align:self-start;align-items:self-start;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:calc(100% - 110px);}} .exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:100%;position:relative;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:20%;}} .exFqMv .floats-partial-middle{position:relative;} .exFqMv .partial-carousel-wrapper .carousel-prev{background:url('data:image/svg+xml;base64,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') no-repeat 17.5px;height:50px;width:61px;display:inline-block;border:0;border-right:1px solid #E3E3E3;padding:0;cursor:pointer;background-position-y:54.35%;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:51px;background-position-x:8px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:59px;background-position-x:16px;}} .exFqMv .partial-carousel-wrapper .carousel-next{background:url('data:image/svg+xml;base64,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') no-repeat 18.5px;height:52px;width:61px;display:inline-block;padding:0px;cursor:pointer;border:0;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:51px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:59px;}} .exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{position:absolute;right:0;bottom:-50px;height:50px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{bottom:0;}} .exFqMv .partial-carousel-wrapper .floats-partial-content{padding:12px;} .exFqMv .partial-carousel-wrapper .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{border-left:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-content{display:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-image:url(https://w2o-xhtml-parsed-preprod.s3-eu-west-1.amazonaws.com/table_thumb.svg);background-repeat:no-repeat;background-position:17px 17px;background-size:100px 70px;border-top:none;min-height:110px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{cursor:pointer;position:absolute;left:17px;top:17px;height:70px;width:100px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding-left:137px;padding-right:0px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{cursor:pointer;position:absolute;top:20px;left:135px;height:20px;width:60px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{color:black;display:block !important;-webkit-text-decoration:none;text-decoration:none;width:auto;margin-left:140px;margin-right:20px;padding:0px 0px 15px 0px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .minimize_btn{display:none !important;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .expand_btn{display:none !important;} @media (max-width:567px){.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-size:60px 45px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{height:45px;width:60px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding:30px 0px 15px 95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{top:30px;left:95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{margin:0px 20px;}} .exFqMv .owl-item{overflow-y:hidden;margin-bottom:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;} .exFqMv .supplementary--docs{display:-ms-flexbox;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;padding-left:2em;} @media (min-width:767.5px){.exFqMv .supplementary--docs{padding-left:1em;}} .exFqMv .supplementary--docs li{-ms-flex:0 0 100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (min-width:991.5px){.exFqMv .supplementary--docs li{-ms-flex:0 0 50%;-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} .exFqMv .supplementary--docs li a::after{content:'';background :url(data:image/svg+xml;base64,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) no-repeat 5px;padding-right:35px;background-size:14px;} .exFqMv .dataset-section .supplementary--dpis-desc{padding-left:19px;} .exFqMv .dataset-section .supplementary--dpis-desc p{margin:10px 0;} .exFqMv .table-group.fixed-width,.exFqMv .table-group.sidewaystable{min-width:auto;} .exFqMv .noliststyle{padding-left:1em;} .exFqMv .noliststyle li{padding-left:0;} .exFqMv .xml-content > hr{display:none;} .exFqMv sup,.exFqMv sub{vertical-align:baseline;position:relative;top:5px;} .exFqMv sup{top:-5px;} @media (min-width:767.5px){.exFqMv a{position:relative;}} .exFqMv a div.tooltip{cursor:auto;position:absolute;width:280px;background:#fff;border:1px solid #adadad;padding:20px;margin:0;display:none;z-index:2;color:#000;} @media (min-width:767.5px){.exFqMv a div.tooltip{width:400px;}} @media (min-width:991.5px){.exFqMv a div.tooltip{width:572px;}} .exFqMv a div.tooltip .cross{position:absolute;right:10px;top:10px;display:block;height:14px;width:14px;cursor:pointer;} .exFqMv a div.tooltip ol{margin:0;padding:0 0 10px 20px;} .exFqMv a div.tooltip ol li{text-align:left;margin:0;} .exFqMv a div.tooltip.left{left:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.left{left:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.left{left:-100px;}} .exFqMv a div.tooltip.right{right:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.right{right:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.right{right:-100px;}} .exFqMv a div.tooltip a.seeRef{padding-left:30px;} .exFqMv .gloss-abbr tr td:first-child{white-space:nowrap;} .exFqMv table.algorithm td{word-break:keep-all;} .exFqMv h4#copyright + p a{word-break:break-word;}
/* sc-component-id: sc-bGbJRg */
.dVCLgr{width:100%;} @media (min-width:991.5px){.dVCLgr{width:19%;}} @media (min-width:1280px){.dVCLgr{width:24%;max-width:350px;}} .dVCLgr p{border:1px solid #E3E3E3;}
/* sc-component-id: sc-bEjcJn */
.jLUVhb{-webkit-flex:1 0 30%;-ms-flex:1 0 30%;flex:1 0 30%;list-style:none;padding:0;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media (min-width:320px) and (max-width:991.5px){.jLUVhb{position:fixed;width:100%;z-index:2;margin:0;margin-top:50px;top:169px;max-height:calc(100vh - 165px);overflow-y:auto;}} @media (min-width:767.5px) and (max-width:991.5px){.jLUVhb{top:179px;}} @media (min-width:991.5px) and (max-width:1200px){.jLUVhb{max-width:354px;-webkit-flex:1 0 20%;-ms-flex:1 0 20%;flex:1 0 20%;}} @media (min-width:1200px){.jLUVhb{-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;max-width:354px;}} .jLUVhb p{margin:0;padding:10px 0;font-size:16px;font-weight:700;line-height:24px;display:none;} @media (min-width:991.5px){.jLUVhb p{display:block;padding:10px 20px;border:1px solid #E3E3E3;border-bottom:0;}} .jLUVhb.links__hidden{display:none;} @media (min-width:991.5px){.jLUVhb.links__hidden{display:block;}} .jLUVhb.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);} @media (min-width:768px){.jLUVhb.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.jLUVhb.translate{-webkit-transform:none;-ms-transform:none;transform:none;}.jLUVhb.translate #leftSectionMenu{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: sc-ePZHVD */
.ewHMLz{color:#4A4A4A;}
/* sc-component-id: sc-likbZx */
.bBmZJZ{font-size:16px;font-weight:500;line-height:20px;color:#4A4A4A;border:1px solid #E3E3E3;border-bottom:0;background-color:#f2f2f2;display:list-item;} @media (min-width:991px){.bBmZJZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.bBmZJZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .bBmZJZ:last-child{border-bottom:1px solid #E3E3E3;} .bBmZJZ a{display:block;padding:10px 20px;}
/* sc-component-id: sc-eKZiaR */
.dzZrgS{position:fixed;width:100%;height:50px;color:#4D8A17;background-color:#F2F2F2;border:none;font-size:16px;line-height:18px;font-weight:500;z-index:2;top:170px;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;text-align:left;border-top:1px solid #FFFFFF;} @media (min-width:320px) and (max-width:991.5px){.dzZrgS{padding-left:15px;border-bottom:4px solid #FFFFFF;}.dzZrgS.is-open{border-bottom:4px solid #F2F2F2;}} @media (min-width:767.5px){.dzZrgS{top:179px;}} @media (min-width:991.5px){.dzZrgS{display:none;}} .dzZrgS .icon__dots{cursor:pointer;-webkit-transform:rotate(90deg) translateY(8px);-ms-transform:rotate(90deg) translateY(8px);transform:rotate(90deg) translateY(8px);margin-right:15px;} @media (min-width:991.5px){.dzZrgS .icon__dots{padding-right:20px;margin-bottom:2px;-webkit-transform:none;-ms-transform:none;transform:none;}} .dzZrgS.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);top:170px;} @media(min-width:991.5px){.dzZrgS.translate{-webkit-transform :translateY(-130px) rotate(90deg);-ms-transform :translateY(-130px) rotate(90deg);transform :translateY(-130px) rotate(90deg);}}
/* sc-component-id: sc-jrIrqw */
.eHMFfo{padding:0;margin:20px 0;} .eHMFfo span{font-size:14px;} .eHMFfo span.isHide{display:none;} .eHMFfo span i{font-style:italic;} .eHMFfo span i.isHide{display:none;}
/* sc-component-id: sc-hjRWVT */
.irNWJI{width:16px;margin:0 2px 2px;}
/* sc-component-id: sc-iQtOjA */
.kfDwZY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kfDwZY:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kfDwZY{margin-top:5px;}}
/* sc-component-id: sc-fHxwqH */
.dMuGGA{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA p:first-child{margin-top:15px;} .dMuGGA p{font-size:14px;line-height:23px;display:block;} .dMuGGA sup{margin-top:-5px;}
/* sc-component-id: sc-cEvuZC */
.XkrFe{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;} .XkrFe.hr__author{margin-bottom:12px;}
/* sc-component-id: sc-cBdUnI */
@media (min-width:320px) and (max-width:991.5px){.hRnXob{display:none;}} @media (min-width:991.5px){.hRnXob{z-index:1;}}
/* sc-component-id: sc-exkUMo */
.hymroZ{background-color:#6ba339;color:#ffffff;display:none;} .hymroZ span.text{padding-left:20px;} @media (min-width:991px){.hymroZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hymroZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-kcDeIU */
.cbcyj{background-color:#f2f2f2;color:#4a4a4a;display:none;} .cbcyj span.text{padding-left:20px;} @media (min-width:991.5px) and (max-width:1279.5px){.cbcyj{display:none !important;}} @media (min-width:991px){.cbcyj{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.cbcyj:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.cbcyj.hide{display:none !important;}}
/* sc-component-id: sc-BngTV */
.hmDWcT{background-color:#f2f2f2;color:#4a4a4a;display:none;} .hmDWcT span.text{padding-left:20px;} @media (min-width:1279.5px){.hmDWcT{display:none !important;}} @media (min-width:991px){.hmDWcT{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hmDWcT:hover{background-color :#5D9230;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.hmDWcT.hide{display:none !important;}}
/* sc-component-id: sc-hBbWxd */
.kdRRST{background-color:#f2f2f2;border-top:1px solid #ffffff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:14px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;padding:20px 55px 20px 25px;} @media (max-width:1279.5px){.kdRRST{padding-right:20px;}} @media (max-width:991.5px){.kdRRST{display:none;}}
/* sc-component-id: sc-dyGzUR */
.cHatnS div{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} .cHatnS div:last-of-type{padding-top:20px;} .cHatnS span{color:#4F4F4F;font-size:20px;font-weight:700;line-height:26px;}
/* sc-component-id: sc-drKuOJ */
.kxdGAZ{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;height:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .kxdGAZ span{padding-top:15px;}
/* sc-component-id: sc-cTjmhe */
@media (min-width:991.5px){.ihmyEq{width:100%;z-index:1;}}
/* sc-component-id: sc-cugefK */
.itFKcQ{background-color:#F2F2F2;color:#4A4A4A;border-top:1px solid #FFFFFF;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:991px){.itFKcQ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.itFKcQ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.itFKcQ.hide{display:none !important;}} .itFKcQ.active .icon-themeable{-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-fnwBNb */
.etzuBr{display:none;}
/* sc-component-id: sc-iNhVCk */
.gWgCNb{background-color:#f2f2f2;border-radius:0;border-top:1px solid #e3e3e3;font-size:16px;color:#4a4a4a;font-weight:500;padding:11px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} @media (min-width:991px){.gWgCNb{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.gWgCNb:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-eAKXzc */
.WHkfb{-webkit-flex:1 0 90%;-ms-flex:1 0 90%;flex:1 0 90%;padding-left:50px;} @media (min-width:767.5px){.WHkfb{padding-left:93px;}} @media (min-width:991.5px){.WHkfb{padding-left:50px;}}
/* sc-component-id: sc-bfYoXt */
.cGuwDn{width:20px;height:24px;}
/* sc-component-id: sc-gbOuXE */
.jGPvPL{width:22px;height:21px;padding:2px;}
/* sc-component-id: sc-dRFtgE */
.jrsDZP{-webkit-flex:1 0 80%;-ms-flex:1 0 80%;flex:1 0 80%;padding-left:26px;} @media (min-width:767.5px){.jrsDZP{padding-left:69px;}} @media (min-width:991.5px){.jrsDZP{padding-left:20px;}} @media (min-width:991.5px) and (max-width:1279.5px){.jrsDZP{display:none;}}
/* sc-component-id: sc-gkFcWv */
.gWTCXQ{display:none;} @media (min-width:991.5px){.gWTCXQ{padding-left:20px;max-width:100px;display:inline;}} @media (min-width:1279.5px){.gWTCXQ{display:none;}}
/* sc-component-id: sc-hUfwpO */
.jHPgUP{width:100%;border-left:1px solid #f2f2f2;border-right:1px solid #f2f2f2;border-bottom:none;cursor:pointer;} .jHPgUP li{background-color:#f2f2f2;} @media (min-width:991px){.jHPgUP li{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.jHPgUP li:hover{background-color :#ffffff;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .jHPgUP h3{display:none;}
/* sc-component-id: sc-imABML */
.ibWUzs{background-color:#f2f2f2;color:#4a4a4a;display:block;border-top:1px solid #ffffff;border-radius:0;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} .ibWUzs .right__icon{padding:0;height:16px;width:20px;} @media (min-width:991px){.ibWUzs{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.ibWUzs:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.ibWUzs.hide{display:none !important;}}
/* sc-component-id: sc-cjHlYL */
.mkXor{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:25%;float:right;margin-top:-49px;} @media (max-width:374px){.mkXor{width:26.5%;}} @media (min-width:992px){.mkXor{display:none;}}
/* sc-component-id: sc-dRaagA */
.dULvrJ{background-color:#6ba339;color:white;-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;z-index:100;padding:14px 16px 10px 19px;border-radius:0px;border-bottom:1px solid #ffffff;} @media (min-width:320px) and (max-width:767px){.dULvrJ{border-bottom:none;padding:16px 16px 14px 16px;font-size:14px;}.dULvrJ .article_toolbar_icon{display:none;}}
/* sc-component-id: sc-fEUNkw */
.dfaOeH{margin-right:16px;width:24px;height:24px;}
/* sc-component-id: sc-dREXXX */
.cqhPZs{width:16px;height:auto;float:right;} @media (min-width:767.5px){.cqhPZs{width:24px;height:24px;}}
/* sc-component-id: sc-nrwXf */
.byflLi{font-size:14px;padding:16px 20px 24px;} @media (max-width:991px){.byflLi{display:none;}}
/* sc-component-id: sc-eitiEO */
.jXeALb{font-size:14px;} .jXeALb:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-bhlBdH */
.UVThf{font-size:14px;font-weight:bold;}
/* sc-component-id: sc-kDhYZr */
.iySbrx{margin:35px 0 0;display:none;} @media(max-width:767px){.iySbrx.mobile_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.iySbrx.row2{margin:15px 0 0;}} @media(min-width:768px){.iySbrx.desktop_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} @media (min-width:991.5px){.iySbrx{margin:0;}}
/* sc-component-id: sc-sPYgB */
.bCmGAV{width:15px;border-bottom:1px solid #E0E0E0;} @media(max-width:767px){.bCmGAV.row2_edge_left{-webkit-flex-basis:10%;-ms-flex-preferred-size:10%;flex-basis:10%;}.bCmGAV.row2_edge_right{-webkit-flex-basis:30%;-ms-flex-preferred-size:30%;flex-basis:30%;}}
/* sc-component-id: sc-dHIava */
.TdHTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;border-bottom:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4D8A17 !important;} .TdHTO:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.TdHTO{width:215px;}} .TdHTO:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}.bmMPie{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4A4A4A !important;} .bmMPie:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.bmMPie{width:215px;}} .bmMPie:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}
/* sc-component-id: sc-bSbAYC */
.fClRDD{border-width:1px;border-style:solid;border-color:#007B8B;background:rgba(0,123,139,0.05);padding:25px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:30px;}
/* sc-component-id: sc-guztPN */
.fexZtq{display:block;margin-left:15px;} @media(min-width:768px){.fexZtq{margin-left:30px;}} .fexZtq br{content:"";display:block;margin-bottom:16px;}
/* sc-component-id: sc-cFlXAS */
.iomKnj{font-family:STIXGeneral;font-size:30px;width:37px;height:37px;-webkit-flex:1 0 37px;-ms-flex:1 0 37px;flex:1 0 37px;border-radius:50%;background:#3396A3;color:#FFFFFF;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-weight:bold;} @media(min-width:768px){.iomKnj{font-size:40px;width:48px;height:48px;-webkit-flex:1 0 48px;-ms-flex:1 0 48px;flex:1 0 48px;}}
/* sc-component-id: sc-OxbzP */
.eEFYIL{width:100%;height:auto;background-color:#4A4A4A;font-family:'IBM Plex Sans',sans-serif;font-size:14px;font-weight:500;color:#fff;padding:15px 20px;line-height:20px;position:fixed;bottom:0px;z-index:3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-transition:-webkit-transform .25s;-webkit-transition:transform .25s;transition:transform .25s;} .eEFYIL a{color:#7ED321;} .eEFYIL p{display:inline;margin:0;} .eEFYIL.hideBanner{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);}
/* sc-component-id: sc-bYnzgO */
.dsXEHZ{background:transparent;border:none;height:20px;width:20px;margin-left:20px;padding:0;cursor:pointer;}
/* sc-component-id: sc-cPuPxo */
.iXKuYd{min-width:20px;height:20px;}
/* sc-component-id: baseContent__Main-sc-134g3di-2 */
.cmzomn{margin-top:140px;} @media (min-width:767.5px){.cmzomn{margin-top:85px;}} @media (min-width:991.5px){.cmzomn{margin-top:70px;min-height:calc(100vh - 334px);}}
/* sc-component-id: threeColumn__ThreeColumnWrapper-sc-1bf4078-0 */
.dDyxFF{width:100%;} @media only screen and (min-width:992px){.dDyxFF{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;padding:0 20px;max-width:1440px;margin:0 auto;}} @media (min-width:991.5px) and (max-width:1100.5px){.dDyxFF .partenership__collabText{font-size:12px;}} @media (min-width:1100.5px) and (max-width:1200.5px){.dDyxFF .partenership__collabText{font-size:14px;}} @media (min-width:991.5px) and (max-width:1071.5px){.dDyxFF .partenership__logoWrapper img{margin-left:20px;margin-bottom:10px;}.dDyxFF .partenership__logoWrapper img:last-child{margin-left:0;margin-bottom:0;}} @media (max-width:1150px){.dDyxFF .journal-metrics-container{display:none;}.dDyxFF .journal_report_link-border-helper{display:none;}}
/* sc-component-id: threeColumn__LeftWrapper-sc-1bf4078-1 */
@media only screen and (min-width:992px){.fkVFlF{width:20%;}} @media only screen and (min-width:1280px){.fkVFlF{width:25%;}}
/* sc-component-id: threeColumn__RightWrapper-sc-1bf4078-2 */
.jzTMLK{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media only screen and (min-width:992px){.jzTMLK{width:20%;margin-bottom:60px;}.jzTMLK.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media only screen and (min-width:1280px){.jzTMLK{width:25%;}}
/* sc-component-id: threeColumn__ContentWrapper-sc-1bf4078-3 */
.bbzREB{margin:0 20px;overflow:hidden;} @media only screen and (min-width:992px){.bbzREB{width:calc(60% - 40px);}} @media only screen and (min-width:1280px){.bbzREB{width:calc(50% - 40px);}}
/* sc-component-id: threeColumn__Content-sc-1bf4078-4 */
.jknsZc{margin:0 auto;overflow:hidden;} @media only screen and (min-width:768px){.jknsZc{max-width:688px;}} @media only screen and (min-width:992px){.jknsZc{max-width:100%;}} @media only screen and (min-width:1075px){.jknsZc{max-width:572px;}}
/* sc-component-id: article__BaseStyle-sc-10qhnp8-0 */
.gnduKR{width:100%;margin-top:170px;} @media (min-width:767.5px){.gnduKR{margin-top:179px;}} @media (min-width:991.5px){.gnduKR{margin-top:180px;min-height:840px;}}
/* sc-component-id: article__StickyStyle-sc-10qhnp8-1 */
.fJLQxX{width:100%;max-width:1440px;z-index:3;-webkit-transition:all 0.5s;transition:all 0.5s;} .fJLQxX.translate{-webkit-transform:translateY(-120px);-ms-transform:translateY(-120px);transform:translateY(-120px);} @media (min-width:767.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: article__SubtitleStyled-sc-10qhnp8-2 */
.elhyhe{background-color:#007b8b;opacity:0.8;color:#fff;margin-bottom:0;margin-top:0;padding:17px 0 17px 20px;line-height:23px;height:60px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:20px;font-weight:500;} @media (min-width:767.5px){.elhyhe{line-height:26px;}} @media (min-width:991.5px){.elhyhe{line-height:50px;padding:5px 0 5px 20px;height:60px;}}
/* sc-component-id: article__JournalMenuTitle-sc-10qhnp8-3 */
.jCfZqq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:16px;font-weight:500;line-height:20px;height:50px;width:100%;background-color:#007b8b;color:#fff;text-align:left;padding-left:14px;padding-right:0;border:0;border-top:1px solid #fff;} .jCfZqq span{font-size:24px;padding-right:14px;} @media (min-width:991.5px){.jCfZqq{display:none;}}
/* sc-component-id: article__WhiteWrapper-sc-10qhnp8-5 */
.bJcSpM{background-color:#fff;display:block;position:relative;} .bJcSpM h1,.bJcSpM h2{color:#fff;} .bJcSpM h2{font-size:20px;} @media (min-width:767.5px){.bJcSpM h2{font-size:25px;}} .bJcSpM h1{font-size:20px;} @media (min-width:767.5px){.bJcSpM h1{font-size:24px;}} @media (min-width:991.5px){.bJcSpM h1{font-size:40px;}}
/* sc-component-id: articleContent__ArticleContentsWrapper-sc-2yl9jy-0 */
.eSvjPB{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} .eSvjPB .author__editor--hr{display:block;}
/* sc-component-id: articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 */
.jntdRu{width:100%;} @media (max-width:991.5px){.jntdRu{margin-top:52px;}} .jntdRu p{margin:12px 0;line-height:20px;} .jntdRu .articlecontent__alignment{width:100%;min-width:306px;padding-left:7px;padding-right:7px;} @media (min-width:346px){.jntdRu .articlecontent__alignment{padding-left:20px;padding-right:20px;}} @media (min-width:767.5px){.jntdRu .articlecontent__alignment{width:543px;margin:auto;padding-left:0px;padding-right:0px;}} @media (min-width:991.5px){.jntdRu .articlecontent__alignment{max-width:612px;width:75%;margin:inherit;margin-left:50px;padding-left:20px;padding-right:20px;}} @media (min-width:1100px){.jntdRu .articlecontent__alignment{margin-left:118px;}} .jntdRu .article__title{padding-bottom:12px;} @media (min-width:767.5px){.jntdRu .article__title{padding-bottom:15px;}} .jntdRu .article__summary{padding-bottom:65px;} @media (min-width:991.5px){.jntdRu .article__summary{padding-bottom:75px;}} @media (min-width:767.5px){.jntdRu #vjs_video_3 button{-webkit-transform:none;-ms-transform:none;transform:none;left:40%;margin-top:0;}} .jntdRu .video-js .vjs-big-play-button{top:calc(50% - 22.5px);left:calc(50% - 50px);} .jntdRu .video-js{margin:20px 0;} .jntdRu a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .jntdRu a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: articleContent__ArticleWrapper-sc-2yl9jy-2 */
.eGVCps{background-position:0px 0px;background-origin:content-box;background-size:99%;margin-top:50px;}
/* sc-component-id: articleContent__EditorWrapper-sc-2yl9jy-3 */
.evMkvU{padding:0;}
/* sc-component-id: articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 */
.fjviok{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:15px 0 30px;border-bottom:1px solid #E3E3E3;} @media (min-width:767.5px){.fjviok{border-top:1px solid #E3E3E3;margin:20px 0 30px;}}
/* sc-component-id: articleContent__PublcationCol-sc-2yl9jy-5 */
.hgKieC{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;max-width:100%;border-right:1px solid #E3E3E3;padding:5px 0 15px;} @media (min-width:767.5px){.hgKieC{padding:5px 0;}} .hgKieC.notPublished{display:none;} @media (min-width:767.5px){.hgKieC.notPublished{display:block;}} @media (max-width:767.5px){.hgKieC.isPublished{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.hgKieC.isPublished span:first-child::after{content:':';padding-right:3px;}} .hgKieC:last-child{border-right:none;}
/* sc-component-id: articleContent__PublicationField-sc-2yl9jy-6 */
.cIribm{display:block;text-align:center;font-size:14px;font-weight:700;}
/* sc-component-id: articleContent__PublicationValue-sc-2yl9jy-7 */
.khHUcu{display:block;text-align:center;font-size:14px;}
/* sc-component-id: articleContent__TextWrapper-sc-2yl9jy-8 */
.fYrLtk{margin:-7px 0 -5px;font-size:14px;}
/* sc-component-id: biblio__Wrapper-sc-1nou1lz-0 */
.eyHfWh{position:relative;} .eyHfWh.hide{display:none;} .eyHfWh hr{position:absolute;left:0;right:0;top:-30px;border-top:1px solid #E3E3E3;border-bottom:0;}.cBTaXT.hide{display:none;} .cBTaXT hr{display:none;}
/* sc-component-id: biblio__BiblioWrapper-sc-1nou1lz-1 */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/_/hindawi-ui/fonts/STIXGeneral-Regular.otf');} .kbSZJl{padding:0 20px 20px;} .kbSZJl .bib__image{display:none;} .kbSZJl .bib__title{font-size:20px;} .kbSZJl .bib__name{font-size:18px;font-family:'STIXGeneral-Bold',serif !important;color:rgb(74,74,74);font-weight:700;} .kbSZJl .bib--split .bib__link .bib__info,.kbSZJl .bib--split .bib__link.bib__link--image .bib__info,.kbSZJl [class*='bib--txt'] .bib__link .bib__info,.kbSZJl [class*='bib--txt'] .bib__link.bib__link--image .bib__info{padding:10px 0 !important;} .kbSZJl .bib__author{font-size:14px;line-height:22px;color:rgb(132,132,132);margin-top:3px;margin-bottom:0px;margin-right:20px;opacity:1;font-family:'IBM Plex Sans',sans-serif;font-weight:500;} .kbSZJl #biblio_sidebar .bib__link{border-top:1px solid rgb(227,227,227) !important;padding-top:5px !important;padding-bottom:5px !important;} .kbSZJl #biblio_sidebar .bib__link:first-child{border-top:0 !important;padding-top:0 !important;} .kbSZJl #biblio_sidebar .bib__link:first-child .bib__info{padding-top:0 !important;} .kbSZJl #biblio_widget .bib--split .bib__link .bib__info,.kbSZJl #biblio_widget .bib--split .bib__link.bib__link--image .bib__info{padding:10px 15px 10px 0 !important;} @media (min-width:767.5px){.kbSZJl{padding:0 40px 20px;}} @media (min-width:991.5px){.kbSZJl{padding:0 20px;}}
/* sc-component-id: biblio__H4-sc-1nou1lz-2 */
.becpDt{font-size:20px;font-family:'IBM Plex Sans';color:#000;font-weight:600;margin-top:34px;margin-bottom:18px;padding:0 20px;}
/* sc-component-id: journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 */
.gbrQxi{display:none;} @media (min-width:991.5px){.gbrQxi{display:block;}.gbrQxi .article_top_toolbar{top:110px;z-index:-100;}.gbrQxi .article_top_toolbar .pdf_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.gbrQxi .article_top_toolbar .ref_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .gbrQxi .article_toolbar_views{margin-top:-58px;display:block;text-align:right;}
/* sc-component-id: journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 */
@media (min-width:991.5px){.isgRZA .article_bottom_toolbar{top:292px;z-index:-10;}}
/* sc-component-id: journal_article__BreadCrumbStyle-sc-12fk6zy-2 */
@media (min-width:991.5px){.bjwAQR{padding:16px 20px 24px;height:60px;}}
/* sc-component-id: journal_article__ArticleBaseStyle-sc-12fk6zy-3 */
.NQpXC .content,.NQpXC .contentWrapper{overflow:visible;}
/* sc-component-id: journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 */
.cYsVdk{max-width:350px;} @media (max-width:991.5px){.cYsVdk{display:none !important;}}
/* sc-component-id: journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 */
.dbAANp{background-color:#f5f5f5;padding:15px 20px 24px 20px;margin-top:2px;margin-bottom:20px;} @media (min-width:991.5px){.dbAANp{margin-top:-64px;margin-bottom:40px;}} .dbAANp .hrTitleRef{padding:0;margin-top:0;font-family:'IBM Plex Sans',sans-serif;} .dbAANp #biblio_widget{padding:0;}</style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-fjdhpX jzXSTA"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-kAzzGY epRoim mobileLogoFlex _1fpqArXPCxgnlv2rXZC2sl _1SoDWGr_FVsil9klRfjnhb"><a class="sc-htpNat bUhGXt link" href="/" aria-label="Home"><img alt="logo" src="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg" class="sc-ckVGcZ gjctdt"/></a></div><div class="sc-jzJRlG jGJLow mobileButtonFlex _2v1j-tLx3hx0tgKcpPzH6B _3wm8FgzqRuRWouJG31YgKx E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kpOJdX kAzjOl"><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-chPdSV hbVEoI icon__search" aria-label="Search"><span class="sc-htoDjs khbeDd icon__search icon-colored _3hSk3ArgsWMFh5QJIGblNr icon-themeable" title="" font-size="24"></span></button><button aria-label="Hamburger Menu" class="sc-cSHVUG ldSkVQ"><span class="sc-htoDjs khbeDd hamburger icon-colored _20YUA8q5mREEBfJm8VsdXV icon-themeable" title="" font-size="24"></span></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cmzomn  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-3 NQpXC"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-cbkKFq kuxTps article__StickyStyle-sc-10qhnp8-1 fJLQxX"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 bJcSpM" href="/journals/ecam/" aria-label=""><h2 class="sc-eHgmQL fTkdCR article__SubtitleStyled-sc-10qhnp8-2 elhyhe _1ZrXcsbATVL_kHOpFAan9k">Evidence-Based Complementary and Alternative Medicine</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 jCfZqq journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu</button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-cjHlYL mkXor"><a class="sc-htpNat bUhGXt link sc-dRaagA dULvrJ article-toolbar-link" href="https://downloads.hindawi.com/journals/ecam/2013/938081.pdf" aria-label="" download=""><img alt=" " class="sc-EHOje jOLhQl sc-fEUNkw dfaOeH article_toolbar_icon" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/>PDF<img alt=" " class="sc-EHOje jOLhQl sc-dREXXX cqhPZs" title="" role="presentation" src="data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMjBweCIgaGVpZ2h0PSIyMnB4IiB2aWV3Qm94PSIwIDAgMjAgMjIiIHZlcnNpb249IjEuMSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayI+CiAgICA8IS0tIEdlbmVyYXRvcjogU2tldGNoIDUzLjIgKDcyNjQzKSAtIGh0dHBzOi8vc2tldGNoYXBwLmNvbSAtLT4KICAgIDx0aXRsZT5JY29ucy9BcnJvdyBSaWdodCBXaGl0ZTwvdGl0bGU+CiAgICA8ZGVzYz5DcmVhdGVkIHdpdGggU2tldGNoLjwvZGVzYz4KICAgIDxkZWZzPgogICAgICAgIDxwYXRoIGQ9Ik0xMSwxMy41ODU3ODY0IEwxMSwyIEMxMSwxLjQ0NzcxNTI1IDExLjQ0NzcxNTMsMSAxMiwxIEMxMi41NTIyODQ3LDEgMTMsMS40NDc3MTUyNSAxMywyIEwxMywxMy41ODU3ODY0IEwxNS4yOTI4OTMyLDExLjI5Mjg5MzIgQzE1LjY4MzQxNzUsMTAuOTAyMzY4OSAxNi4zMTY1ODI1LDEwLjkwMjM2ODkgMTYuNzA3MTA2OCwxMS4yOTI4OTMyIEMxNy4wOTc2MzExLDExLjY4MzQxNzUgMTcuMDk3NjMxMSwxMi4zMTY1ODI1IDE2LjcwNzEwNjgsMTIuNzA3MTA2OCBMMTIuNzA3MTA2OCwxNi43MDcxMDY4IEMxMi4zMTY1ODI1LDE3LjA5NzYzMTEgMTEuNjgzNDE3NSwxNy4wOTc2MzExIDExLjI5Mjg5MzIsMTYuNzA3MTA2OCBMNy4yOTI4OTMyMiwxMi43MDcxMDY4IEM2LjkwMjM2ODkzLDEyLjMxNjU4MjUgNi45MDIzNjg5MywxMS42ODM0MTc1IDcuMjkyODkzMjIsMTEuMjkyODkzMiBDNy42ODM0MTc1MSwxMC45MDIzNjg5IDguMzE2NTgyNDksMTAuOTAyMzY4OSA4LjcwNzEwNjc4LDExLjI5Mjg5MzIgTDExLDEzLjU4NTc4NjQgWiBNMiwxNyBDMiwxNi40NDc3MTUzIDIuNDQ3NzE1MjUsMTYgMywxNiBDMy41NTIyODQ3NSwxNiA0LDE2LjQ0NzcxNTMgNCwxNyBMNCwyMCBDNCwyMC41NTIyODQ3IDQuNDQ3NzE1MjUsMjEgNSwyMSBMMTksMjEgQzE5LjU1MjI4NDcsMjEgMjAsMjAuNTUyMjg0NyAyMCwyMCBMMjAsMTcgQzIwLDE2LjQ0NzcxNTMgMjAuNDQ3NzE1MywxNiAyMSwxNiBDMjEuNTUyMjg0NywxNiAyMiwxNi40NDc3MTUzIDIyLDE3IEwyMiwyMCBDMjIsMjEuNjU2ODU0MiAyMC42NTY4NTQyLDIzIDE5LDIzIEw1LDIzIEMzLjM0MzE0NTc1LDIzIDIsMjEuNjU2ODU0MiAyLDIwIEwyLDE3IFoiIGlkPSJwYXRoLTEiPjwvcGF0aD4KICAgIDwvZGVmcz4KICAgIDxnIGlkPSJTeW1ib2xzIiBzdHJva2U9Im5vbmUiIHN0cm9rZS13aWR0aD0iMSIgZmlsbD0ibm9uZSIgZmlsbC1ydWxlPSJldmVub2RkIj4KICAgICAgICA8ZyBpZD0iU2lkZWJhcnMvRGVza3RvcC9BcnRpY2xlLVNpZGViYXIiIHRyYW5zZm9ybT0idHJhbnNsYXRlKC0yOTEuMDAwMDAwLCAtNzEuMDAwMDAwKSI+CiAgICAgICAgICAgIDxnIGlkPSJTdWJtaXQiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAuMDAwMDAwLCA0OS4wMDAwMDApIj4KICAgICAgICAgICAgICAgIDxnIGlkPSJUeXBlLWFuZC1pY29ucyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMjAuMDAwMDAwLCAxOC4wMDAwMDApIj4KICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iSWNvbnMvRG93bmxvYWQtV2hpdGUiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDI2Ni4wMDAwMDAsIDAuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJkb3dubG9hZCIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMy4wMDAwMDAsIDMuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8bWFzayBpZD0ibWFzay0yIiBmaWxsPSJ3aGl0ZSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHVzZSB4bGluazpocmVmPSIjcGF0aC0xIj48L3VzZT4KICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvbWFzaz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgaWQ9IkNvbWJpbmVkLVNoYXBlIiBmaWxsPSIjMDAwMDAwIiBmaWxsLXJ1bGU9Im5vbnplcm8iIHhsaW5rOmhyZWY9IiNwYXRoLTEiPjwvdXNlPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPGcgaWQ9IkNPTE9SLy13aGl0ZSIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjRkZGRkZGIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxyZWN0IGlkPSJSZWN0YW5nbGUiIHg9IjAiIHk9IjAiIHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCI+PC9yZWN0PgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICA8L2c+CiAgICAgICAgPC9nPgogICAgPC9nPgo8L3N2Zz4=" height="24"/></a></div><nav id="journal__nav" class="sc-hGoxap dEfJbW article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl fSPaCp journalNavCheck" color="">Journal overview<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/contents/year/2022/" aria-label="Table of Contents">Table of Contents</a><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl bVEEaH journalNavCheck" color="">Special Issues<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-jtRfpW OGgkt submit__button journalNavCheck" href="https://review.hindawi.com/submit?journal=ecam" aria-label="" target="" id=""><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ jUTgTa" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Submit</span></span><span class="sc-htoDjs kNoiZu sc-dqBHgY cQgXqt fileArrow icon-colored undefined icon-themeable" title="" font-size="16"></span></a><div class="sc-krDsej ewCAZX hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-itybZL kdvWPs journalSubmenuCheck"><span class="sc-htoDjs gvAGTV sc-fzsDOv hAFFGk journalSubmenuCheck icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><div class="sc-dTdPqK lkWWFY hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-kUaPvJ ehYbwJ"><div class="sc-gPWkxV legory"></div><div class="sc-gPWkxV legory"></div></div><div class="sc-jVODtj epgILe"></div><span class="sc-fONwsr kCfRMJ"></span></div></nav></div><div class="sc-nrwXf byflLi breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-2 bjwAQR article"><a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/" aria-label="Evidence-Based Complementary and Alternative Medicine">Evidence-Based Complementary and Alternative Medicine</a> / <a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/contents/year/2013/" aria-label="2013">2013</a> / <span class="sc-bhlBdH UVThf">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 dDyxFF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-eKZiaR dzZrgS section__button  " id="sectionButton"><span class="sc-htoDjs diutvq icon__dots dots__detector icon-colored _3n-7Ho7DlfjMlZbrRr9Q4a icon-themeable" title="" font-size="22"></span>Article Sections</button><div class="sc-bEjcJn jLUVhb static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-cbkKFq prcY sc-bGbJRg dVCLgr left_section_menu"><p>On this page</p><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abstract" aria-label="">Abstract</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#introduction" aria-label="">Introduction</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#methods" aria-label="">Methods</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#results" aria-label="">Results</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#discussion" aria-label="">Discussion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#conclusion" aria-label="">Conclusion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#acknowledgments" aria-label="">Acknowledgments</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#references" aria-label="">References</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="sc-kDhYZr iySbrx desktop_tabs"><div class="sc-sPYgB bCmGAV"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO" href="/journals/ecam/2013/938081/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/ecam/2016/2467420/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row1"><div class="sc-sPYgB bCmGAV row1_edge_left"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO row1_link" href="/journals/ecam/2013/938081/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row1_link" href="/journals/ecam/2016/2467420/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV row1_edge_right"></div></div><div class="sc-bSbAYC fClRDD"><span class="sc-cFlXAS iomKnj">!</span><span class="sc-guztPN fexZtq alert__message">A <b>Corrigendum</b> for this article has been published.
  To view the article details, please click the Corrigendum tab above.</span></div><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 eGVCps"><div class="sc-chbbiW mBGSe article_header_class"><div class="sc-kxynE fgGykB"><span class="sc-cooIXK gQxyld">Special Issue</span><h2 class="sc-fcdeBU bVtmCk">Herbal Medicine as an Alternative Medicine for Treating Diabetes: The Global Burden</h2><a class="sc-htpNat bUhGXt link sc-gmeYpB hSHJbi" href="/journals/ecam/si/621829/" aria-label="">View this Special Issue</a><hr class="sc-clNaTc ktFfKO"/></div><p class="sc-kZmsYB bkiEfx article_type">Research Article | <!-- -->Open Access</p><div class="sc-RcBXQ ztvYg article_citation">Volume<!-- --> <!-- -->2013<!-- --> <span class="sc-fZwumE cUsFHx">|</span>Article ID<!-- --> <!-- -->938081<!-- --> <span class="sc-fZwumE cUsFHx">| </span><a class="sc-htpNat bUhGXt link sc-fQejPQ duuwge" href="https://doi.org/10.1155/2013/938081" aria-label="Doi-link">https://doi.org/10.1155/2013/938081</a></div><div class="sc-LKuAh lcOiDF article_full_citation"><div class="sc-hzNEM gsmOCv isHide"><p>Nabilatul Hani Mohd-Radzman, Wan Iryani Wan Ismail, Siti Safura Jaapar, Zainah Adam, Aishah Adam<!-- -->,<!-- --> <!-- -->&quot;<span class="adjust-article-svg-size">Stevioside from <i>Stevia rebaudiana</i> Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes</span>&quot;,<!-- --> <i>Evidence-Based Complementary and Alternative Medicine</i>,<!-- --> <!-- -->vol. <!-- -->2013<!-- -->,<!-- --> <!-- -->Article ID <!-- -->938081<!-- -->,<!-- --> <!-- -->8<!-- --> <!-- --> <!-- --> <!-- -->pages<!-- -->,<!-- --> <!-- -->2013<!-- -->.<!-- --> <!-- -->https://doi.org/10.1155/2013/938081</p></div><button class="sc-hSdWYo etauus sc-iBEsjs kPshFw" color="">Show citation</button></div><h1 class="sc-iRbamj jZOxOO sc-iSDuPN kRoxOt article_title adjust-article-svg-size heading-title">Stevioside from <i>Stevia rebaudiana</i> Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes</h1></div><div class="sc-jrIrqw eHMFfo article_authors"><hr class="sc-cEvuZC XkrFe hr__author"/><span class="">Nabilatul Hani Mohd-Radzman<!-- -->,<sup>1</sup> </span><span class=""><b>Wan Iryani Wan Ismail</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a>,<sup>1</sup> </span><span class="">Siti Safura Jaapar<!-- -->,<sup>1</sup> </span><span class="">Zainah Adam<!-- -->,<sup>2</sup> <!-- --> and </span><span class="">Aishah Adam<sup>1</sup></span><div class="sc-fHxwqH dMuGGA isHide"><p><sup>1</sup><span>Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia</span></p><p><sup>2</sup><span>Medical Technology Division, Malaysian Nuclear Agency, Bangi, 43000 Kajang, Selangor, Malaysia</span></p></div><button class="sc-hSdWYo etauus sc-iQtOjA kfDwZY" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>Bechan Sharma</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">19 Mar 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Revised</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">13 Oct 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">24 Oct 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">11 Dec 2013</span></div></div></div><article class="sc-jtRlXQ exFqMv article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Stevioside from <i>Stevia rebaudiana</i> has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects <i>in vitro</i>. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17%, making it impossible to determine its IC<sub>50</sub>. Stevioside increased glucose uptake activities by 2.1 times (<svg height="15.2875" id="M1" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>) in normal conditions and up to 4.4 times (<svg height="15.2875" id="M2" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>Epidemic-level emergence of many noncommunicable diseases as a result of modern lifestyle and dietary habits is worrying. Insulin resistance has commonly been linked to metabolic syndromes resulting in type 2 diabetes mellitus, as well as obesity. In fact, it is purported to underlie the progression of type 2 diabetes [<a href="#B1">1</a>] and in cases of burn trauma, hyperlipidaemia and cancer cachexia [<a href="#B2">2</a>]. It is important to note that insulin resistance occurs in an impaired insulin-signalling pathway, indicative of patients with type 2 diabetes. In normal individuals with fully functioning insulin-signalling activities, insulin will be secreted once blood glucose levels are increased following intake of food, and will subsequently bind to its receptor. This binding action will lead to several stages of signalling and phosphorylation cascades, resulting in migration of glucose transporter 4 (GLUT4) from cytoplasm to cellular membrane to take up extracellular glucose. However, in a state of insulin resistance, these signalling activities and cascades are interrupted, blocking said migration of GLUT4, if not disrupting the proteins expression altogether [<a href="#B3">3</a>]. Hence, a better understanding of these mechanisms will possibly lead to breakthroughs in unravelling the secrets of both insulin resistance and diabetes.</p><p>As is often the case, traditional communities use local herbs in their folk and traditional medicines for treating hyperglycaemia and diabetes. Among these is <i>Stevia rebaudiana</i> Bertoni, a perennial herb commonly grown in tropical and subtropical regions, specifically in South America and Asia. In recent years, Malaysians too have taken a particular interest in this herb as it has been promoted as a sweetening alternative to sucrose, beneficial specifically for those with obesity and diabetes. <i>Stevia rebaudiana</i> has little to no caloric value despite its sweetening abilities, thus will not jeopardise patients blood glucose levels, while fulfilling their cravings for sweet food and drinks [<a href="#B4">4</a>]. <i>Stevia rebaudiana</i> is sweet due to its constituents of steviol glycosides including stevioside, rebaudioside A and rebaudioside C [<a href="#B5">5</a>]. Furthermore, previous reports showed this plant has antioxidant [<a href="#B6">6</a>] and antihyperglycaemic [<a href="#B7">7</a>] properties, increasing its potential for use in adjuvant management of diabetes mellitus and associated conditions. There has been little investigation into such assertions which has prompted this study to evaluate how stevioside can affect insulin sensitivity, particularly through observation of glucose uptake, and expression of proteins involved in insulin-signalling pathway at a cellular level through use of 3T3-L1 adipocytes.</p><h4 id="methods">2. Methods</h4><h5 id="sec2.1">2.1. Materials</h5><p>&#13;
					3T3-L1 preadipocytes were commercially acquired from ATCC (American Type Culture Collections, USA). Chemicals, including stevioside, cell supplements, and media, were mostly purchased from Sigma-Aldrich Co. (Germany) and Lonza (USA). Ultima Gold LLT scintillation cocktail and 2-deoxy-[1-3H]-glucose were commercially obtained from Perkin Elmer (USA). The antidiabetic drug rosiglitazone maleate (AVANDIA) was bought from a local drugstore. <i><i></i></i>-Actin, p-IRS1, and pY20 primary antibodies, and donkey anti-goat and goat anti-rabbit horseradish peroxidase (HRP) conjugated secondary antibodies were purchased from Santa Cruz (USA).</p><h5 id="sec2.2">2.2. Cell Culture and Differentiation</h5><p>&#13;
					3T3-L1 preadipocytes were cultured in Dulbeccos Modified Eagles Media (DMEM). Cells were later differentiated with supplements of insulin, dexamethasone (DMX), and 3-isobutyl-1-methyl-xanthine (IBMX) following the procedures described by Ahn et al. [<a href="#B8">8</a>] and Ismail et al. [<a href="#B9">9</a>]. In order to induce insulin resistance, cells were treated with tumour necrosis factor-<i><i></i></i> (TNF-<i><i></i></i>) at 1.0ng/mL for 4 days prior to treatment.</p><h5 id="sec2.3">2.3. Oil Red-O Staining</h5><p>3T3-L1 cells were washed with phosphate-buffered saline (PBS) before being fixed with a solution of 10% formaldehyde in PBS. After overnight incubation, the solution was discarded and Oil Red-O dye was introduced to cells for 10 minutes at room temperature. Subsequently, excess dye was washed with de-ionised water. The stain was later eluted out with 100% isopropanol and measured spectrophotomerically at 520nm.</p><h5 id="sec2.4">2.4. Cell Viability Test</h5><p>3T3-L1 adipocytes were cultured in 96-well plates and were pretreated with stevioside (25300<i></i>M) for 14, 24, 48, and 72 hours. After pretreatment, the cells received 5mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and were further incubated for 4 hours. The purple formazan crystals were then dissolved with dimethyl sulfoxide (DMSO) before their absorbance values were read on a microplate reader at 590nm.</p><h5 id="sec2.5">2.5. Glucose Uptake Assay</h5><p>Glucose uptake levels by differentiated 3T3-L1 adipocytes were analysed using a method previously described by Adam et al. [<a href="#B10">10</a>], with minor modifications. Briefly, 3T3-L1 adipocytes were differentiated on 12-well plates. For insulin-resistance studies, cells were initially induced to insulin resistance with TNF-<i><i></i></i> treatment, as mentioned earlier. Cells were serum-starved for 2 hours. Next, they were washed with Krebs-Ringer bicarbonate (KRB) buffer and preincubated with a range of stevioside concentrations (30150<i></i>M and 30120<i></i>M) for half an hour, with or without insulin addition, with rosiglitazone as a positive control. 2-Deoxy-[1-3H]-glucose (1<i></i>Ci/mL) was then added to each well to initiate glucose uptake, and incubated for a further hour. Cells were then  washed with ice-cold KRB buffer and solubilised by 0.1% sodium dodecyl sulphate (SDS). Finally, samples were collected and mixed with 15mL of Ultima Gold LLT scintillation cocktail before being measured in a liquid scintillation counter.</p><h5 id="sec2.6">2.6. Western Blotting</h5><p>3T3-L1 cells were cultured and differentiated in 6-well plates. Cells were given TNF-<i><i></i></i> to induce insulin resistance, as described earlier, prior to treatment with stevioside. Treatments of stevioside and rosiglitazone maleate were given, in 60 and 90<i></i>M concentrations, for 24 hours. Cells were stimulated with insulin for 5 minutes prior to harvesting. From the preparation of cell lysates and loading of samples to Western blot analysis, procedures described by Ismail et al. [<a href="#B9">9</a>] were followed, with minor modifications.</p><h5 id="sec2.7">2.7. Statistical Analysis</h5><p>Data were presented as mean  standard error mean (SEM) for a given number of tests. The results were processed statistically by one-way analysis of variance (ANOVA) followed by Dunnetts post-hoc tests, using the Sigma Plot version 12 software. Statistically different means were recognised at <svg height="15.2875" id="M3" style="vertical-align:-3.50804pt;width:57.974998px;" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>.</p><h4 id="results">3. Results</h4><h5 id="sec3.1">3.1. Oil Red-O Staining</h5><p>Effects of the supplements (insulin, DMX, and IBMX) on adipocyte differentiation are presented in Figure <a href="fig1/" target="_blank">1</a>. In order to proceed with further experiments, adipocyte differentiation was confirmed by conducting the Oil Red-O staining procedure. Lipid stain from fully differentiated adipocytes was eluted out and measured quantitatively in a spectrophotometer, where the readings were found to be significantly increased when compared to control group.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig1"><div class="floats-partial-content fig-content-fig1"><div class="partial-carousel--single-image"><img alt="" name="938081.fig.001" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.001.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 1</span><a aria-label="full view" class="caption-partial-url" href="fig1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of induction of differentiation on lipid accumulation in 3T3-L1 cells, presented by Oil Red-O staining. To quantify lipid accumulation in cells as a result of differentiation, the stain was eluted with 100% isopropanol and measured spectrophotometrically at 520nm. Mean  SEM (<svg height="11.125" id="M4" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>). *Significantly different from control (<svg height="15.2875" id="M5" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>, ANOVA &amp; Dunnetts test).</table></div></div></div><h5 id="sec3.2">3.2. MTT Cytotoxicity Test</h5><p>Cells were previously differentiated to mature adipocytes before treatment with stevioside (25300<i></i>M) for 14, 24, 48, and 72 hours. Cell viability was determined from absorbance readings at 590nm, corresponding to formazan crystals formed by living cells (Figure <a href="fig2/" target="_blank">2</a>). There were no significant differences in cell viabilities in any of the stevioside treatment groups, at any treatment period, with the exception of those treated for a period of 72 hours. Viability of cells treated with 250<i></i>M of stevioside for 72 hours was reduced by 17% at most. No half-maximal inhibitory concentration (IC<sub>50</sub>) was found, as cell viability did not fall lower than the 80% benchmark.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig2"><div class="floats-partial-content fig-content-fig2"><div class="partial-carousel--single-image"><img alt="(a)" name="938081.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="938081.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="938081.fig.002c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="938081.fig.002d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig2"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="938081.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="938081.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="938081.fig.002c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="938081.fig.002d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig2"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 2</span><a aria-label="full view" class="caption-partial-url" href="fig2/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Viability of 3T3-L1 adipocytes treated with stevioside for (a) 14 hours, (b) 24 hours, (c) 48 hours, and (d) 72 hours. Mean  SEM (<svg height="11.075" id="M6" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.075" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.8)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.8)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.8)"><path d="M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z" id="x34"></path></g>
</svg>). Statistically significant compared to control (*<svg height="15.2875" id="M7" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>, **<svg height="15.2875" id="M8" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, and ***<svg height="15.2875" id="M9" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ANOVA &amp; Dunnetts test).</table></div></div></div><h5 id="sec3.3">3.3. Glucose Uptake Assay</h5><h6 id="sec3.3.1">3.3.1. Optimum Insulin Concentration</h6><p>Prior to investigating effects of stevioside on glucose uptake in 3T3-L1 adipocytes, separate assays were conducted to find the optimum concentrations of insulin and TNF-<i><i></i></i> to be used. From Figure <a href="fig3/#a" target="_blank">3(a)</a>, it can be observed that starting from 100nM of insulin, there was a highly significant increase in glucose uptake, with maximum uptake at 125nM. There was no significant difference between these two groups. Therefore, 100nM insulin was selected as the optimum concentration to be used for further experiments.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig3"><div class="floats-partial-content fig-content-fig3"><div class="partial-carousel--single-image"><img alt="(a)" name="938081.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="938081.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig3"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="938081.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="938081.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig3"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 3</span><a aria-label="full view" class="caption-partial-url" href="fig3/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Glucose uptake in 3T3-L1 adipocytes exposed to (a) insulin and (b) TNF-<i></i>. Optimum insulin concentration to stimulate glucose uptake was 100nM, while optimum TNF-<i></i> concentration to reduce glucose uptake was 1.0ng/mL. Mean  SEM (<svg height="11.075" id="M10" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.075" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.8)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.8)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.8)"><path d="M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z" id="x34"></path></g>
</svg>). Statistically significant compared to control (*<svg height="15.2875" id="M11" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>, **<svg height="15.2875" id="M12" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ***<svg height="15.2875" id="M13" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ANOVA &amp; Dunnetts test).</table></div></div></div><p>A separate glucose uptake assay was conducted to find the optimum TNF-<i><i></i></i> concentration for inducing an insulin-resistant state in 3T3-L1 adipocytes. TNF-<i><i></i></i> reduced glucose uptake in the cells up to a concentration of 1.0ng/mL, beyond which there was an increase in glucose uptake at 2.5ng/mL (Figure <a href="fig3/#b" target="_blank">3(b)</a>). Since glucose uptake went down furthest at 1.0ng/mL, this concentration was selected as the optimum TNF-<i><i></i></i> concentration to induce insulin resistance in cells.</p><h6 id="sec3.3.2">3.3.2. Glucose Uptake in Normal 3T3-L1 Adipocytes</h6><p>Glucose uptake assay was next conducted on normal, non-insulin-resistant adipocytes to study effects of stevioside. Glucose uptake by adipocytes was increased by treatment with stevioside or with rosiglitazone (Figure <a href="fig4/" target="_blank">4</a>). Stevioside (30<i></i>M) elicited significant increase in glucose uptake, in both insulin-stimulated and non-insulin-stimulated groups. However, glucose uptake was higher in the insulin-stimulated group, by 2.1 times (<svg height="15.2875" id="M14" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>) compared to control. This was better than what was observed in cells that were treated with rosiglitazone maleate, where glucose uptake in presence of insulin was increased by 1.7 times (<svg height="15.2875" id="M15" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>) at a far higher concentration of 120<i></i>M.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig4"><div class="floats-partial-content fig-content-fig4"><div class="partial-carousel--single-image"><img alt="(a)" name="938081.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="938081.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="938081.fig.004c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="938081.fig.004d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig4"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="938081.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="938081.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="938081.fig.004c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="938081.fig.004d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig4"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 4</span><a aria-label="full view" class="caption-partial-url" href="fig4/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of stevioside and rosiglitazone maleate on glucose uptake in normal 3T3-L1 adipocytes. (a) Treatment with stevioside or rosiglitazone maleate with insulin stimulation. (b) Treatment with stevioside or rosiglitazone maleate without insulin stimulation, (c) insulin-stimulated and non-insulin-stimulated groups treated with rosiglitazone maleate, and (d) insulin-stimulated and non-insulin-stimulated groups treated with stevioside. Mean  SEM (<svg height="11.125" id="M16" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>). Statistically significant compared to control (***<svg height="15.2875" id="M17" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ANOVA &amp; Dunnetts test).</table></div></div></div><h6 id="sec3.3.3">3.3.3. Glucose Uptake in TNF-<i></i> Induced Adipocytes</h6><p>3T3-L1 cells were induced to insulin resistance using TNF-<i><i></i></i>, to test whether stevioside could exert similar effects on these cells as on normal adipocytes in terms of enhancing glucose uptake. Cells were pretreated with TNF-<i><i></i></i> prior to stevioside treatment and their glucose uptake was measured. In insulin-resistant adipocytes, stevioside was still able to stimulate glucose uptake although at a higher concentration of 90<i></i>M compared to the previous 30<i></i>M observed in normal adipocytes (Figure <a href="fig5/" target="_blank">5</a>). Maximum increase in glucose uptake was observed in rosiglitazone-treated group (90<i></i>M) without insulin stimulation, with an elevation of up to 4.6 times (<svg height="15.2875" id="M18" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>) when compared to control. This was followed by treatment with stevioside (90<i></i>M) with insulin stimulation, which elevated glucose uptake by 4.4-times (<svg height="15.2875" id="M19" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig5"><div class="floats-partial-content fig-content-fig5"><div class="partial-carousel--single-image"><img alt="(a)" name="938081.fig.005a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="938081.fig.005b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="938081.fig.005c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="938081.fig.005d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig5"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="938081.fig.005a" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="938081.fig.005b" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="938081.fig.005c" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="938081.fig.005d" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig5"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 5</span><a aria-label="full view" class="caption-partial-url" href="fig5/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of stevioside and rosiglitazone maleate on glucose uptake in TNF-<i><i></i></i> induced insulin-resistant 3T3-L1 adipocytes. (a) Treatment with stevioside or rosiglitazone maleate with insulin stimulation. (b) Treatment with stevioside or rosiglitazone maleate without insulin stimulation, (c) insulin-stimulated and non-insulin-stimulated groups treated with rosiglitazone maleate, and (d) insulin-stimulated and non-insulin-stimulated groups treated with stevioside. Mean  SEM (<svg height="11.125" id="M20" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>). Statistically significant compared to control (*<svg height="15.2875" id="M21" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>, **<svg height="15.2875" id="M22" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ***<svg height="15.2875" id="M23" style="vertical-align:-3.50804pt" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36&#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z" id="x1D45D"></path></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>, ANOVA &amp; Dunnetts test). RM: rosiglitazone maleate, Svs: stevioside.</table></div></div></div><h6 id="sec3.3.4">3.3.4. Western Blotting</h6><p>In this study, expressions of two proteins (p-IRS1 and pY20) that are essential to the insulin-signalling pathway were measured by Western blotting technique. Both proteins were poorly expressed or not expressed at all in the insulin-resistant control group (Figure <a href="fig6/" target="_blank">6</a>). Treatment with stevioside led to expression of both proteins while treatment with rosiglitazone elicited an increase in expression of pY20, though the effects of both treatments were hardly distinguishable from those observed in normal, non-insulin-resistant cells.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig6"><div class="floats-partial-content fig-content-fig6"><div class="partial-carousel--single-image"><img alt="" name="938081.fig.006" src="https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.006.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 6</span><a aria-label="full view" class="caption-partial-url" href="fig6/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Band intensities observed via Western blotting, showing the different expression levels of phosphorylated insulin receptor substrate 1 (p-IRS1) and phosphorylated tyrosine (pY20), in groups treated with stevioside (Svs) and rosiglitazone maleate (RM) in comparison to the normal and insulin-resistant (IR) groups. <i><i></i>-</i>actin was used as a loading control. The experiment was repeated thrice.</table></div></div></div><h4 id="discussion">4. Discussion</h4><p>Aim of this study was to investigate effects of stevioside on insulin sensitivity of 3T3-L1 cells. Oil Red-O is a common lipid stain used to colour lipid droplets <i>in vitro</i>, for quantification and for microscopic and imaging purposes. This specific staining method was used here to determine the degree to which adipocyte differentiation process (also called adipogenesis) had progressed since droplets secreted by adipocytes upon full differentiation to mature adipocytes will be stained (also referred to as lipid positive) [<a href="#B11">11</a>]. Microscopic observation also revealed that lipid droplets were present in cytoplasm of fully differentiated adipocytes in abundance, compared to their absence in preadipocytes before the differentiation process.</p><p>As confirmation, there was a significant increase in absorbance values of eluted Oil Red-O stains from mature differentiated adipocytes (Figure <a href="fig1/" target="_blank">1</a>). The stains from mature adipocytes were increased by 2.4 times (<svg height="15.2875" id="M24" style="vertical-align:-3.50804pt;width:57.974998px;" version="1.1" viewbox="0 0 57.974998 15.2875" width="57.974998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x35"></use></g>
</svg>) when compared to control, which was the stain from empty wells; and were 4.2 times (<svg height="15.2875" id="M25" style="vertical-align:-3.50804pt;width:66.137497px;" version="1.1" viewbox="0 0 66.137497 15.2875" width="66.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45D"></use></g><g transform="matrix(.017,-0,0,-.017,14.851,10.862)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,29.555,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,37.715,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,41.59,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,49.75,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,57.909,10.862)"><use xlink:href="#x31"></use></g>
</svg>) higher when compared to preadipocytes. This showed that the insulin-DMX-IBMX supplements combination was successful at hormonally triggering adipocyte differentiation in cells, most possibly via activation of peroxisome proliferator activator receptor <i></i> (PPAR<i></i>) and CCAAT/enhancer binding protein <i></i> (C/EBP<i></i>), as reported by Jin et al. [<a href="#B12">12</a>].</p><p>Fully differentiated 3T3-L1 adipocytes were then subjected to MTT assay to determine effect of stevioside on cell morphology and viability. 3T3-L1 Cells were treated with stevioside at concentrations ranging from 25 to 300<i></i>M, for several different treatment periods: 14, 24, 48, and 72 hours. Treatment for 14 hours was done as it was the stipulated doubling time for 3T3-L1 adipocytes [<a href="#B13">13</a>]. Viability of cells was not markedly altered by exposure to stevioside except at concentrations greater than 100<i></i>M following incubation for 72 hours. Even then cell viability was still higher than 80% with a maximum decrease of only 17%. Thus, median inhibitory concentration (IC<sub>50</sub>) could not be estimated from this study. Some slight, nonsignificant increase in cell viability of 3T3-L1 adipocytes was observed as has been previously reported [<a href="#B11">11</a>, <a href="#B14">14</a>, <a href="#B15">15</a>]. It can be surmised that stevioside did not exert cytotoxicity on 3T3-L1 adipocytes.</p><p>To test effects of stevioside on insulin-sensitivity of 3T3-L1 adipocytes, its effects on glucose uptake by the adipocytes was determined. Radioactively labelled glucose uptake assays were conducted with use of antidiabetic agent, rosiglitazone as a positive control, as previously reported [<a href="#B10">10</a>].</p><p>Prior to subjecting 3T3-L1 adipocytes to stevioside, response of the cells to insulin and to TNF-<i></i> were determined in separate assays to estimate optimum concentrations. These studies showed that glucose uptake was elevated with increase in insulin concentration in concentration-dependent manner reaching a plateau at 100nM of insulin. This insulin concentration was taken as  the optimum concentration for use in further glucose uptake assays using 3T3-L1 adipocytes as previously reported [<a href="#B16">16</a>].</p><p>TNF-<i><i></i></i> has been implicated in the progression of insulin resistance; it disrupts phosphorylation of several proteins involved in insulin-signalling pathway, including IRS1, tyrosine, and most importantly, the downregulation of glucose transporter 4 (GLUT4) [<a href="#B3">3</a>, <a href="#B17">17</a>]. TNF-<i><i></i></i> is also implicated in a number of catabolic states linked to insulin resistance such as sepsis and cancer even though its exact mechanism of actions remains unclear [<a href="#B18">18</a>].</p><p>TNF-<i><i></i></i> caused a maximal decrease in glucose uptake at 1ng/mL, beyond which glucose uptake was increased when compared to control. This observation contradicted initial expectation of a concentration-dependent decrease in glucose uptake by TNF-<i><i></i></i>, as was previously reported [<a href="#B19">19</a>].</p><p>Normally differentiated, mature 3T3-L1 adipocytes which were not exposed to TNF-<i><i></i></i> were used to evaluate effect of stevioside on insulin sensitivity in normal, non-insulin-resistant state to ascertain effects of its usage in health. Our data showed that stevioside was better than the positive control, rosiglitazone, at increasing glucose uptake in normal adipocytes. Glucose uptake was maximally increased by 30<i></i>M of stevioside, both in presence or in absence of insulin stimulation, surpassing that of rosiglitazone at 120<i></i>M.</p><p>In TNF-<i></i> induced insulin resistance, glucose uptake was maximally increased by rosiglitazone or insulin at 90<i></i>M either in presence or absence of insulin. Since effect of rosiglitazone on glucose uptake was not different from that of stevioside, it may be concluded that both treaments were equally effective at enhancing glucose uptake in insulin-resistant cells.</p><p>There appeared to be interaction between rosiglitazone and insulin in the insulin-resistant state with regards to glucose-uptake, which was lower in presence of 100nM insulin compared to in its absence. This observation was not seen with stevioside as presence of insulin further elevated glucose uptake compared to its absence. A similar trend of enhanced glucose uptake by stevioside and rosiglitazone was  observed in normal adipocytes. It may be assumed that steviosides interaction with insulin was unaffected by insulin resistance unlike that of rosiglitazone except higher concentration of stevioside was needed to elicit significant increase in glucose uptake during insulin-resistant state compared to normal state.  The different behaviour of insulin-stimulated versus non-insulin stimulated  cells to rosiglitazone has important bearing in hyperinsulinaemic states which often occur in insulin resistance, though not always. It is possible that stevioside is suitable for use in hyperinsulinaemic states, which, besides  diabetes, often occur in certain cancers [<a href="#B20">20</a>].</p><p>This study investigated two proteinsthe phosphorylated insulin receptor substrate 1 (p-IRS1), and phosphorylated tyrosine (pY20) that act upstream of the insulin-signalling pathway. Our data showed  both proteins were poorly expressed or not expressed at all in insulin-resistant control group, which imply disruptions in the insulin-signalling pathway as previously reported by Solomon et al. [<a href="#B17">17</a>]. Such disruptions were successfully counteracted by stevioside which restored expression of both proteins, while rosiglitazone was also seen to increased expression of pY20 in insulin-resistant cells. Expression of pY20 was elevated  by treatment with rosiglitazone or stevioside (60<i></i>M &amp; 90<i></i>M) which provided support for potential ability of stevioside at sensitising cells to insulin signalling. p-IRS1  expression was observed in normal cells and in those treated with stevioside, although the bands  were of  low resolutions and intensities. No  p-IRS1 bands were observed in insulin-resistant cells, including those treated with rosiglitazone. This showed that stevioside was able to restore p-IRS1 expressions, similar to those observed in normal group. Stevioside possibly have an effect upstream of the insulin-signalling pathway, by elevating levels of pY20 and probably p-IRS1 as well, which will result in GLUT4 translocation to increase uptake of extracellular glucose. Antihyperglycemic effects of stevioside on cell metabolism as a whole has also been previously reported [<a href="#B21">21</a>].</p><h4 id="conclusion">5. Conclusion</h4><p>Stevioside proved to be as effective as the antidiabetic agent, rosiglitazone, at enhancing glucose uptake in normal 3T3-L1 adipocytes or in cells induced to insulin resistance via exposure to TNF-<i></i>. In normal adipocytes, stevioside at a concentration that was a quarter that of rosiglitazone produced greater increase in glucose uptake than the antidiabetic agent, both in absence or presence of insulin-stimulation. In insulin-resistant cells, stevioside was as effective as rosiglitazone as similar concentrations of both produced comparable stimulation of glucose uptake in absence or presence of insulin. Enhancement of glucose uptake by stevioside was accompanied by increased expression  of p-IRS1 and pY20, denoting involvement of GLUT-4 translocation. Further studies are needed to unravel mechanisms underlying use of stevioside in adjuvant management of diabetes mellitus and its associated complications.</p><h4 id="acknowledgments">Acknowledgments</h4><p>This research was funded by the Fundamental Research Grant Scheme (FRGS) 600-RMI/ST/FRGS 5/3 Fst (52/2011) under Universiti Teknologi MARA and provided by the Ministry of Higher Education, Malaysia.</p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">J.-P. Bastard, M. Maachi, C. Lagathu et al., Recent advances in the relationship between obesity, inflammation, and insulin resistance, <i>European Cytokine Network</i>, vol. 17, no. 1, pp. 412, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20the%20relationship%20between%20obesity,%20inflammation,%20and%20insulin%20resistance&author=J.-P. Bastard&author=M. Maachi&author=C. Lagathu et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B2">N. Houstis, E. D. Rosen, and E. S. Lander, Reactive oxygen species have a causal role in multiple forms of insulin resistance, <i>Nature</i>, vol. 440, no. 7086, pp. 944948, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nature04634">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Reactive%20oxygen%20species%20have%20a%20causal%20role%20in%20multiple%20forms%20of%20insulin%20resistance&author=N. Houstis&author=E. D. Rosen&author=&author=E. S. Lander&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B3">B. B. Kahn and J. S. Flier, Obesity and insulin resistance, <i>Journal of Clinical Investigation</i>, vol. 106, no. 4, pp. 473481, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Obesity%20and%20insulin%20resistance&author=B. B. Kahn &author=J. S. Flier&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B4">S. D. Anton, C. K. Martin, H. Han et al., Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels, <i>Appetite</i>, vol. 55, no. 1, pp. 3743, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.appet.2010.03.009">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20stevia,%20aspartame,%20and%20sucrose%20on%20food%20intake,%20satiety,%20and%20postprandial%20glucose%20and%20insulin%20levels&author=S. D. Anton&author=C. K. Martin&author=H. Han et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B5">G. Brahmachari, L. C. Mandal, R. Roy, S. Mondal, and A. K. Brahmachari, Stevioside and related compounds&#x2014;molecules of pharmaceutical promise: a critical overview, <i>Archiv der Pharmazie</i>, vol. 344, no. 1, pp. 519, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ardp.201000181">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Stevioside%20and%20related%20compoundsmolecules%20of%20pharmaceutical%20promise:%20a%20critical%20overview&author=G. Brahmachari&author=L. C. Mandal&author=R. Roy&author=S. Mondal&author=&author=A. K. Brahmachari&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B6">I.-S. Kim, M. Yang, O.-H. Lee, and S.-N. Kang, The antioxidant activity and the bioactive compound content of <i>Stevia rebaudiana</i> water extracts, <i>Food Science and Technology</i>, vol. 44, no. 5, pp. 13281332, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.lwt.2010.12.003">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20antioxidant%20activity%20and%20the%20bioactive%20compound%20content%20of%20Stevia%20rebaudiana%20water%20extracts&author=I.-S. Kim&author=M. Yang&author=O.-H. Lee&author=&author=S.-N. Kang&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B7">S. K. Yadav and P. Guleria, Steviol glycosides from stevia: biosynthesis pathway review and their application in foods and medicine, <i>Critical Reviews in Food Science and Nutrition</i>, vol. 52, no. 11, pp. 988998, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1080/10408398.2010.519447">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Steviol%20glycosides%20from%20stevia:%20biosynthesis%20pathway%20review%20and%20their%20application%20in%20foods%20and%20medicine&author=S. K. Yadav &author=P. Guleria&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B8">M.-Y. Ahn, K. D. Katsanakis, F. Bheda, and T. S. Pillay, Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling, <i>Journal of Biological Chemistry</i>, vol. 279, no. 20, pp. 2152621532, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M307740200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Primary%20and%20essential%20role%20of%20the%20adaptor%20protein%20APS%20for%20recruitment%20of%20both%20c-Cbl%20and%20its%20associated%20protein%20CAP%20in%20insulin%20signaling&author=M.-Y. Ahn&author=K. D. Katsanakis&author=F. Bheda&author=&author=T. S. Pillay&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B9">W. I. W. Ismail, J. A. King, K. Anwar, and T. S. Pillay, Indinavir and nelfinavir inhibit proximal insulin receptor signalling and salicylate abrogates inhibition: potential role of NF<math id="M26" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>&#x3ba;</mi></mrow></math>B pathway, <i>Journal of Cellular Biochemistry</i>, vol. 9999, pp. 110, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Indinavir%20and%20nelfinavir%20inhibit%20proximal%20insulin%20receptor%20signalling%20and%20salicylate%20abrogates%20inhibition:%20potential%20role%20of%20NFB%20pathway&author=W. I. W. Ismail&author=J. A. King&author=K. Anwar&author=&author=T. S. Pillay&publication_year=2013" target="_blank">Google Scholar</a></span><li id="B10">Z. Adam, S. Khamis, A. Ismail, and M. Hamid, <i>Ficus deltoidea</i>: a potential alternative medicine for diabetes mellitus, <i>Evidence-Based Complementary and Alternative Medicine</i>, vol. 2012, Article ID 632763, 12 pages, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1155/2012/632763">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Ficus%20deltoidea:%20a%20potential%20alternative%20medicine%20for%20diabetes%20mellitus&author=Z. Adam&author=S. Khamis&author=A. Ismail&author=&author=M. Hamid&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B11">H. Masuno, S. Okamoto, J. Iwanami et al., Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells, <i>Toxicological Sciences</i>, vol. 75, no. 2, pp. 314320, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1093/toxsci/kfg203">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%204-nonylphenol%20on%20cell%20proliferation%20and%20adipocyte%20formation%20in%20cultures%20of%20fully%20differentiated%203T3-L1%20cells&author=H. Masuno&author=S. Okamoto&author=J. Iwanami et al.&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B12">L. Jin, W. Fang, B. Li et al., Inhibitory effect of Andrographolide in 3T3-L1 adipocytes differentiation through the PPAR<i>&#x3b3;</i> pathway, <i>Molecular and Cellular Endocrinology</i>, vol. 358, no. 1, pp. 8187, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.mce.2012.02.025">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibitory%20effect%20of%20Andrographolide%20in%203T3-L1%20adipocytes%20differentiation%20through%20the%20PPAR%20pathway&author=L. Jin&author=W. Fang&author=B. Li et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B13">Z. Qiu, Y. Wei, N. Chen, M. Jiang, J. Wu, and K. Liao, DNA synthesis and mitotic clonal expansion is not required for 3T3-L1 preadipocyte differentiation into adipocytes, <i>Journal of Biological Chemistry</i>, vol. 276, no. 15, pp. 1198811995, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M011729200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=DNA%20synthesis%20and%20mitotic%20clonal%20expansion%20is%20not%20required%20for%203T3-L1%20preadipocyte%20differentiation%20into%20adipocytes&author=Z. Qiu&author=Y. Wei&author=N. Chen&author=M. Jiang&author=J. Wu&author=&author=K. Liao&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B14">M. Nagayama, T. Uchida, and K. Gohara, Temporal and spatial variations of lipid droplets during adipocyte division and differentiation, <i>Journal of Lipid Research</i>, vol. 48, no. 1, pp. 918, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1194/jlr.M600155-JLR200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Temporal%20and%20spatial%20variations%20of%20lipid%20droplets%20during%20adipocyte%20division%20and%20differentiation&author=M. Nagayama&author=T. Uchida&author=&author=K. Gohara&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B15">X. Wang, H. Liu, L. Zhao et al., Effects of crude polysaccharides from <i>Catathelasma venticosum</i> on the proliferation and differentiation of 3T3-L1 cells, <i>Agricultural Journal</i>, vol. 7, no. 3, pp. 187190, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.3923/aj.2012.187.190">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20crude%20polysaccharides%20from%20Catathelasma%20venticosum%20on%20the%20proliferation%20and%20differentiation%20of%203T3-L1%20cells&author=X. Wang&author=H. Liu&author=L. Zhao et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B16">H. Ruan, N. Hacohen, T. R. Golub, L. van Parijs, and H. F. Lodish, Tumor necrosis factor-<i>&#x3b1;</i> suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-<i>&#x3ba;</i>B activation by TNF-<i>&#x3b1;</i> is obligatory, <i>Diabetes</i>, vol. 51, no. 5, pp. 13191336, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Tumor%20necrosis%20factor-%20suppresses%20adipocyte-specific%20genes%20and%20activates%20expression%20of%20preadipocyte%20genes%20in%203T3-L1%20adipocytes:%20nuclear%20factor-B%20activation%20by%20TNF-%20is%20obligatory&author=H. Ruan&author=N. Hacohen&author=T. R. Golub&author=L. van Parijs&author=&author=H. F. Lodish&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B17">S. S. Solomon, S. K. Mishra, M. R. Palazzolo, A. E. Postlethwaite, and J. M. Seyer, Identification of specific sites in the TNF-<i>&#x3b1;</i> molecule promoting insulin resistance in H-411E cells, <i>The Journal of Laboratory and Clinical Medicine</i>, vol. 130, no. 2, pp. 139146, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Identification%20of%20specific%20sites%20in%20the%20TNF-%20molecule%20promoting%20insulin%20resistance%20in%20H-411E%20cells&author=S. S. Solomon&author=S. K. Mishra&author=M. R. Palazzolo&author=A. E. Postlethwaite&author=&author=J. M. Seyer&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B18">J. K. Sethi and G. S. Hotamisligil, The role of TNF<i>&#x3b1;</i> in adipocyte metabolism, <i>Seminars in Cell and Developmental Biology</i>, vol. 10, no. 1, pp. 1929, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20role%20of%20TNF%20in%20adipocyte%20metabolism&author=J. K. Sethi &author=G. S. Hotamisligil&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B19">G. S. Hotamisligil, D. L. Murray, L. N. Choy, and B. M. Spiegelman, Tumor necrosis factor <i>&#x3b1;</i> inhibits signaling from the insulin receptor, <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 91, no. 11, pp. 48544858, 1994. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.91.11.4854">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Tumor%20necrosis%20factor%20%20inhibits%20signaling%20from%20the%20insulin%20receptor&author=G. S. Hotamisligil&author=D. L. Murray&author=L. N. Choy&author=&author=B. M. Spiegelman&publication_year=1994" target="_blank">Google Scholar</a></span><li id="B20">D. H. Cohen and D. LeRoith, Obesity, type 2 diabetes, and cancer: the insulin and IGF connection, <i>Endocrine-Related Cancer</i>, vol. 19, pp. F27F45, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1530/ERC-11-0374">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Obesity,%20type%202%20diabetes,%20and%20cancer:%20the%20insulin%20and%20IGF%20connection&author=D. H. Cohen &author=D. LeRoith&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B21">S. Gregersen, P. B. Jeppesen, J. J. Holst, and K. Hermansen, Antihyperglycemic effects of stevioside in type 2 diabetic subjects, <i>Metabolism</i>, vol. 53, no. 1, pp. 7376, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.metabol.2003.07.013">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antihyperglycemic%20effects%20of%20stevioside%20in%20type%202%20diabetic%20subjects&author=S. Gregersen&author=P. B. Jeppesen&author=J. J. Holst&author=&author=K. Hermansen&publication_year=2004" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright &#xa9; 2013 Nabilatul Hani Mohd-Radzman et al. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 eyHfWh journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 dbAANp article_widget biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">More related articles</h4><div id="biblio_widget" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 jzTMLK rightWrapper" id="rightSectionMenu"><div><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 gbrQxi article_sticky_top_toolbar"><div class="sc-cBdUnI hRnXob article_top_toolbar"><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-exkUMo hymroZ pdf_desktop button__group" href="https://downloads.hindawi.com/journals/ecam/2013/938081.pdf" aria-label="" target="_blank" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/><span class="text">PDF</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-kcDeIU cbcyj ref_desktop" href="/journals/ecam/2013/938081.ris" aria-label="" target="" id="toolbar__dcNavLarge"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Download Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-BngTV hmDWcT ref_desktop" href="/journals/ecam/2013/938081.ris" aria-label="" target="" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 isgRZA article_sticky_bottom_toolbar"><div class="sc-cTjmhe ihmyEq article_bottom_toolbar"><div class="sc-cugefK itFKcQ accordion" property="background-color" color="#D8D8D8" id="toolbar__dofNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Download other formats</span><span class="sc-gkFcWv gWTCXQ">More</span></span><span class="sc-htoDjs bMdQcY sc-gbOuXE jGPvPL icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="11"></span></div><div class="sc-fnwBNb etzuBr"><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2013/938081.epub" aria-label="ePub" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">ePub</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2013/938081.xml" aria-label="XML" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">XML</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><a class="sc-htpNat bUhGXt link sc-imABML ibWUzs" href="https://reprints.hindawi.com/938081/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8" id="toolbar__opcNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Order printed copies</span><span class="sc-gkFcWv gWTCXQ">Order</span></span><span class="sc-htoDjs kNoiZu sc-gbOuXE jGPvPL right__icon icon-colored _32KP5uexH-Bgs7Kj8Gk1Tz icon-themeable" title="" font-size="16"></span></a><div class="sc-hBbWxd kdRRST"><div class="sc-dyGzUR cHatnS"><div>Views<span>3937</span></div><div>Downloads<span>1716</span></div></div><div><div class="sc-drKuOJ kxdGAZ"><span class="__dimensions_badge_embed__" data-doi="10.1155/2013/938081" data-style="small_circle"></span>Citations</div></div></div><nav class="sc-bRBYWo fXBKFa sc-hUfwpO jHPgUP" id="toolbar__iconNav"><h3 class="sc-Rmtcm hNPrIr">Share Post</h3><ul class="sc-hzDkRC bnbfTS"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2013/938081&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialTwitter" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2013/938081" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialLinkedin" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialLinkedin.svg" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2013/938081" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialFacebook" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialFacebook-HINDAWI.svg" height="24"/></a></li><li class="iconBorder"><div class="wechat-container"><img alt=" " class="sc-EHOje jOLhQl socialWechat" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><div class="addthis_inline_share_toolbox"></div><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5ec5076f7164b9b5"></script></div></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes&amp;body=https://doi.org/10.1155/2013/938081" aria-label="Sharing on Mail" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialMail" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li></ul></nav></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 cBTaXT journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 cYsVdk biblioWrapperRight biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">Related articles</h4><div id="biblio_sidebar" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div></div></div></main><footer class="sc-jKJlTe inBNwS"><section class="sc-eNQAEJ dkutRV"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-hMqMXs hlGpbO mobile">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="/about/" aria-label="About us">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="/about/contact/" aria-label="Contact us">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="/publishing-partnerships/" aria-label="Partnerships">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="/blog/" aria-label="Blog">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="/journals/" aria-label="Journals">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link print_editions" href="/print-editions/" aria-label="Print editions">Print editions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="/publish-research/authors/" aria-label="Authors">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="/publish-research/editors/" aria-label="Editors">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="/publish-research/reviewers/" aria-label="Reviewers">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="/open-archives-initiative/" aria-label="Open Archives Initiative">Open Archives Initiative</a></li><li><a class="sc-htpNat bUhGXt link fraud_prevention" href="/preventing-and-protecting-against-fraud/" aria-label="Fraud prevention">Fraud prevention</a></li></ul></nav><div class="sc-hMqMXs hlGpbO desktop">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNDAiIGhlaWdodD0iNDAiIHZpZXdCb3g9IjAgMCA0MCA0MCIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNMTcuMjk3MyAyMy43ODM4TDIzLjc4MzggMjBMMTcuMjk3MyAxNi4yMTYyVjIzLjc4MzhaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PHBhdGggZmlsbC1ydWxlPSJldmVub2RkIiBjbGlwLXJ1bGU9ImV2ZW5vZGQiIGQ9Ik0wIDIwQzAgOC45NTU5OSA4Ljk1NTk5IDAgMjAgMEMzMS4wNDQgMCA0MCA4Ljk1NTk5IDQwIDIwQzQwIDMxLjA0NCAzMS4wNDQgNDAgMjAgNDBDOC45NTU5OSA0MCAwIDMxLjA0NCAwIDIwWk0zMS45ODI0IDI2LjAzMjRDMzIuNDk2OSAyNC4wNzY1IDMyLjQ5NjkgMjAuMDIwNCAzMi40OTY5IDIwLjAyMDRDMzIuNDk2OSAyMC4wMjA0IDMyLjUxNzcgMTUuOTQ0MiAzMS45ODI0IDEzLjk4ODNDMzEuNjk0IDEyLjkxNzggMzAuODQ5OSAxMi4wNzM0IDI5Ljc3OTQgMTEuNzg1M0MyNy44MjM1IDExLjI1IDIwIDExLjI1IDIwIDExLjI1QzIwIDExLjI1IDEyLjE3NjUgMTEuMjUgMTAuMjIwNiAxMS43NjQ4QzkuMTcwNTMgMTIuMDUyOSA4LjMwNTY2IDEyLjkxNzggOC4wMTc1OCAxMy45ODgzQzcuNTAyNzUgMTUuOTQ0MiA3LjUwMjc1IDIwIDcuNTAyNzUgMjBDNy41MDI3NSAyMCA3LjUwMjc1IDI0LjA3NjUgOC4wMTc1OCAyNi4wMTE3QzguMzA1OTcgMjcuMDgyMiA5LjE1MDA5IDI3LjkyNjYgMTAuMjIwNiAyOC4yMTQ3QzEyLjE5NyAyOC43NSAyMCAyOC43NSAyMCAyOC43NUMyMCAyOC43NSAyNy44MjM1IDI4Ljc1IDI5Ljc3OTQgMjguMjM1MkMzMC44NDk5IDI3Ljk0NzEgMzEuNjk0IDI3LjEwMyAzMS45ODI0IDI2LjAzMjRaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PC9zdmc+" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-iAyFgw gCiATD"><a class="sc-htpNat bUhGXt link" href="/privacy/" aria-label="Privacy Policy">Privacy Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/terms/" aria-label="Terms of Service">Terms of Service<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/responsible-disclosure-policy/" aria-label="Responsible Disclosure Policy">Responsible Disclosure Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/cookie-policy/" aria-label="Cookie Policy">Cookie Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/copyright/" aria-label="Copyright">Copyright<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/modern-slavery-statement/" aria-label="Modern slavery statement">Modern slavery statement<!-- --> </a></section></div></footer><div class="sc-OxbzP eEFYIL  advWrapper hideBanner"><span><p>Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.&nbsp;<a href="https://www.hindawi.com/article-year-award/" rel="noopener noreferrer" target="_blank">Read the winning articles</a>.</p>
</span><button class="sc-bYnzgO dsXEHZ"><img alt=" " class="sc-EHOje iiusBg sc-cPuPxo iXKuYd" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></button></div></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues","pe":"/publish-research/authors/publication-ethics","fr":"/publish-research/reviewers","fe":"/publish-research/editors"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://review.hindawi.com/submit?journal={journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to\u0026nbsp;\u003ca href=\"mailto:{journal_subcode}@hindawi.com\"\u003e{journal_subcode}@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eGeneral enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\r\n"},"open_access":{"title":"Open Access","text":"\u003cp dir=\"ltr\"\u003e\u003cem\u003e{journal_name}\u003c/em\u003e is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our \u003ca href=\"https://www.hindawi.com/copyright/\"\u003ecopyright page\u003c/a\u003e.\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","theme":"HINDAWI","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","social_share_options":["facebook","twitter","linkedin","wechat","mail"],"use_journal_etoc_pages":true,"GTM_ID":"GTM-MQ4MGW","SITE_NAME":"Hindawi","secureSiteUrl":"https://www.hindawi.com","features":{"isMaintenanceOn":false},"useLazyLoad":false,"hasJournalReportPage":false},"data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2019-10/ECAM_hero.jpg?itok=9epnhPpu","alt":"Evidence-Based Complementary and Alternative Medicine"},"text_colour_code":"#ffffff","about_journal":"/journals/ecam/about","is_wiley_partner":0,"metrics_data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","url":"/journals/ecam","apc":{"label":"APC","value":"$2550","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/ecam/ecam.banner.small.jpg","alt":"Evidence-Based Complementary and Alternative Medicine"},"metrics":[{"label":"Acceptance rate","value":"27%"},{"label":"Submission to final decision","value":"68 days"},{"label":"Acceptance to publication","value":"33 days"},{"label":"CiteScore","value":"3.000"},{"label":"Journal Citation Indicator","value":"0.730"},{"label":"Impact Factor","value":"2.629"}],"logos":[],"toolbar_metrics_or_logo":"metrics","partner_link":false},"links_block":[{"title":"Author guidelines","link":"/journals/ecam/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/ecam/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/ecam/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":0,"journal_subcode":"ecam","journal_issn":"1741-427X","hide_marketing_msg":0,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/ecam/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/ecam/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"meta_info":{"title":"Evidence-Based Complementary and Alternative Medicine | Hindawi","meta_data":[{"name":"title","content":"Evidence-Based Complementary and Alternative Medicine | Hindawi"},{"name":"description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:site_name","content":"Hindawi"},{"property":"og:url","content":"current_url"},{"property":"og:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"property":"og:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"name":"twitter:site","content":"Hindawi"},{"name":"twitter:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"twitter:url","content":"current_url"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"}]},"journal_header_uses_logo":false,"global_manuscript_link":"https://review.hindawi.com/submit?journal=ecam","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null}},"meta":{"meta_data":[{"name":"title","content":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"},{"rel":"canonical","href":"https://www.hindawi.com/journals/ecam/2013/938081/"},{"name":"description","content":"Stevioside from \u003ci  \u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci  \u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17\u0026#x25;, making it impossible to determine its IC\u003csub  \u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M1\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath id=\"x1D45D\" d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath id=\"x3C\" d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath id=\"x30\" d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath id=\"x2E\" d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath id=\"x31\" d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" /\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M2\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"/\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"name":"twitter:title","content":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"},{"property":"og:description","content":"Stevioside from \u003ci  \u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci  \u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17\u0026#x25;, making it impossible to determine its IC\u003csub  \u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M1\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath id=\"x1D45D\" d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath id=\"x3C\" d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath id=\"x30\" d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath id=\"x2E\" d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath id=\"x31\" d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" /\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M2\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"/\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."},{"name":"twitter:description","content":"Stevioside from \u003ci  \u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci  \u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17\u0026#x25;, making it impossible to determine its IC\u003csub  \u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M1\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath id=\"x1D45D\" d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath id=\"x3C\" d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath id=\"x30\" d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath id=\"x2E\" d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath id=\"x31\" d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" /\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M2\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"/\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."},{"name":"citation_title","content":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"},{"name":"citation_author","content":"Mohd-Radzman, Nabilatul Hani"},{"name":"citation_author","content":"Ismail, Wan Iryani Wan"},{"name":"citation_author","content":"Jaapar, Siti Safura"},{"name":"citation_author","content":"Adam, Zainah"},{"name":"citation_author","content":"Adam, Aishah"},{"name":"citation_journal_title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2013},{"name":"citation_year","content":"2013"},{"name":"citation_date","content":"2013/12/11"},{"name":"citation_online_date","content":"2013/12/11"},{"name":"citation_doi","content":"https://doi.org/10.1155/2013/938081"},{"name":"citation_issn","content":"1741-427X"},{"name":"citation_abstract","content":"Stevioside from \u003ci  \u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci  \u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17\u0026#x25;, making it impossible to determine its IC\u003csub  \u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M1\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath id=\"x1D45D\" d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath id=\"x3C\" d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath id=\"x30\" d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath id=\"x2E\" d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath id=\"x31\" d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" /\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M2\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"/\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_pdf_url","content":"https://downloads.hindawi.com/journals/ecam/2013/938081.pdf"},{"name":"citation_xml_url","content":"https://downloads.hindawi.com/journals/ecam/2013/938081.xml"},{"name":"dc.creator","content":"Mohd-Radzman, Nabilatul Hani"},{"name":"dc.creator","content":"Ismail, Wan Iryani Wan"},{"name":"dc.creator","content":"Jaapar, Siti Safura"},{"name":"dc.creator","content":"Adam, Zainah"},{"name":"dc.creator","content":"Adam, Aishah"},{"name":"dc.title","content":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes"},{"name":"dc.description","content":"Stevioside from \u003ci  \u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci  \u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17\u0026#x25;, making it impossible to determine its IC\u003csub  \u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M1\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath id=\"x1D45D\" d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#xA;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath id=\"x3C\" d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath id=\"x30\" d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#xA;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath id=\"x2E\" d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" /\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath id=\"x31\" d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" /\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg     style=\"vertical-align:-3.50804pt;width:66.137497px;\" id=\"M2\" height=\"15.2875\" version=\"1.1\" viewBox=\"0 0 66.137497 15.2875\" width=\"66.137497\"  xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns=\"http://www.w3.org/2000/svg\"\u003e\n\t\n\t\t\n\t\t\t\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"/\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"/\u003e\u003c/g\u003e\n\n\t\t\n\t\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2013/938081"},{"name":"dc.type","content":"Research Article"},{"name":"dc.date","content":"2013/12/11"},{"name":"dcterms.issued","content":"2013/12/11"},{"name":"prism.publicationDate","content":"2013/12/11"},{"name":"prism.volume","content":2013},{"name":"prism.section","content":"Research Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2013/938081"},{"name":"prism.issn","content":"1741-427X"},{"name":"dc.source","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"prism.publicationName","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"authors","content":"Nabilatul Hani Mohd-Radzman | Wan Iryani Wan Ismail | ... | Aishah Adam"}],"title":"Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes","current_url":"https://www.hindawi.com/journals/ecam/2013/938081/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Print editions","external":0,"relative":"/print-editions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1},{"title":"Fraud prevention","external":0,"relative":"/preventing-and-protecting-against-fraud","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Responsible Disclosure Policy","external":0,"relative":"/responsible-disclosure-policy","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":1},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1},{"title":"Modern slavery statement","external":0,"relative":"/modern-slavery-statement","expanded":0,"enabled":1}]},"config":{"footer_config_logo":"","footer_config_copyright":""}},"headers":{},"journalCode":"ecam"},"isLiveUrl":true,"advMsg":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/ecam/2013/938081/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","headerData":{"status":200,"data":{"header_menu_items":{"header-menu":[{"title":"Journals","external":0,"link":"/journals","expanded":0,"enabled":1},{"title":"Publish with us","external":0,"link":"/publish-research","expanded":0,"enabled":1},{"title":"Publishing partnerships","external":0,"link":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"About us","external":0,"link":"/about","expanded":0,"enabled":1},{"title":"Blog","external":0,"link":"/blog","expanded":0,"enabled":1}]}},"headers":{}},"theme":"HINDAWI","sharingOptions":["facebook","twitter","linkedin","wechat","mail"],"useJournalEtocPages":true,"isUserFromChina":false,"useLazyLoad":false,"hasJournalReportPage":false},"ceased":false,"journalAlias":"/journals/ecam","journalNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/ecam/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/ecam/about","key":"about"},{"title":"Editorial Board","link":"/journals/ecam/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/ecam/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/ecam/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/ecam/apc","key":"apc"}]},{"title":"For authors","link":"/journals/ecam/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/ecam/contents/year/2022","children":[]},{"title":"Special Issues","link":"/journals/ecam/si","children":[{"title":"Open Special Issues","link":"/journals/ecam/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/ecam/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/ecam","article":{"retracted":false,"related_articles":[{"title":"Research Article","link":"/journals/ecam/2013/938081/","childrens":[]},{"title":"Corrigendum","link":"/journals/ecam/2016/2467420","childrens":[{"special_issue":false,"volume":"2016","pdf":"downloads.hindawi.com/journals/ecam/2016/2467420.pdf","abstract":"","id":"2467420","type":"Corrigendum","title":"Corrigendum to \u0026#x201c;Stevioside from \u003ci\u003eStevia rebaudiana\u003c/i\u003e Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes\u0026#x201d;","date":"09 Aug 2016","journal":"Evidence-Based Complementary and Alternative Medicine","alias":"/journals/ecam/2016/2467420","authors":[{"name":"Nabilatul Hani Mohd-Radzman"},{"name":"Wan Iryani Wan Ismail"},{"name":"Siti Safura Jaapar"},{"name":"Zainah Adam"},{"name":"Aishah Adam"}],"reference":"/journals/ecam/2016/2467420.ris"}]}],"id":"938081","title":"Stevioside from \u003ci\u003eStevia rebaudiana\u003c/i\u003e Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes","title_toc":"Stevioside from \u003ci\u003eStevia rebaudiana\u003c/i\u003e Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes","type":"Research Article","volume":2013,"pub_year":"2013","article_id":"938081","pages":8,"first_page":"","last_page":"","issue_no":"","doi":"https://doi.org/10.1155/2013/938081","doi_simple":"10.1155/2013/938081","shorten_url":"https://doi.org/10.1155/2013/938081","inPress":false,"academic_editors":[{"name":"Bechan Sharma"}],"guest_editors":[],"published_date":"11 Dec 2013","received_date":"19 Mar 2013","revised_date":"13 Oct 2013","accepted_date":"24 Oct 2013","authors":[{"name":"Nabilatul Hani Mohd-Radzman","email":"","orcid":"","sup":["1"]},{"name":"Wan Iryani Wan Ismail","email":"moc.liamg@inayrinaw","orcid":"","sup":["1"]},{"name":"Siti Safura Jaapar","email":"","orcid":"","sup":["1"]},{"name":"Zainah Adam","email":"","orcid":"","sup":["2"]},{"name":"Aishah Adam","email":"","orcid":"","sup":["1"]}],"affiliations":[{"id":"1","text":"Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia"},{"id":"2","text":"Medical Technology Division, Malaysian Nuclear Agency, Bangi, 43000 Kajang, Selangor, Malaysia"}],"is_special_issue":1,"special_issue_details":{"title":"Herbal Medicine as an Alternative Medicine for Treating Diabetes: The Global Burden","url":"/journals/ecam/si/621829"},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eStevioside from \u003ci\u003eStevia rebaudiana\u003c/i\u003e has been reported to exert antihyperglycemic effects in both rat and human subjects. There have been few studies on these effects \u003ci\u003ein vitro\u003c/i\u003e. In this paper, radioactive glucose uptake assay was implemented in order to assess improvements in insulin sensitivity in 3T3-L1 cells by elevation of glucose uptake following treatment with stevioside. Oil Red-O staining and MTT assay were utilized to confirm adipocyte differentiation and cell viability, respectively. Findings from this research showed a significant increase in absorbance values in mature adipocytes following Oil Red-O staining, confirming the differentiation process. Stevioside was noncytotoxic to 3T3-L1 cells as cell viability was reduced by a maximum of 17%, making it impossible to determine its IC\u003csub\u003e50\u003c/sub\u003e. Stevioside increased glucose uptake activities by 2.1 times (\u003csvg height=\"15.2875\" id=\"M1\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) in normal conditions and up to 4.4 times (\u003csvg height=\"15.2875\" id=\"M2\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) in insulin-resistant states. At times, this increase  was higher than that seen in positive control group treated with rosiglitazone maleate, an antidiabetic agent. Expressions of pY20 and p-IRS1 which were measured via Western blot were improved by stevioside treatment. In conclusion, stevioside has  direct effects on 3T3-L1 insulin sensitivity via increase in glucose uptake and enhanced expression of proteins involved in insulin-signalling pathway.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003eEpidemic-level emergence of many noncommunicable diseases as a result of modern lifestyle and dietary habits is worrying. Insulin resistance has commonly been linked to metabolic syndromes resulting in type 2 diabetes mellitus, as well as obesity. In fact, it is purported to underlie the progression of type 2 diabetes [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e] and in cases of burn trauma, hyperlipidaemia and cancer cachexia [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. It is important to note that insulin resistance occurs in an impaired insulin-signalling pathway, indicative of patients with type 2 diabetes. In normal individuals with fully functioning insulin-signalling activities, insulin will be secreted once blood glucose levels are increased following intake of food, and will subsequently bind to its receptor. This binding action will lead to several stages of signalling and phosphorylation cascades, resulting in migration of glucose transporter 4 (GLUT4) from cytoplasm to cellular membrane to take up extracellular glucose. However, in a state of insulin resistance, these signalling activities and cascades are interrupted, blocking said migration of GLUT4, if not disrupting the proteins expression altogether [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. Hence, a better understanding of these mechanisms will possibly lead to breakthroughs in unravelling the secrets of both insulin resistance and diabetes.\u003c/p\u003e\u003cp\u003eAs is often the case, traditional communities use local herbs in their folk and traditional medicines for treating hyperglycaemia and diabetes. Among these is \u003ci\u003eStevia rebaudiana\u003c/i\u003e Bertoni, a perennial herb commonly grown in tropical and subtropical regions, specifically in South America and Asia. In recent years, Malaysians too have taken a particular interest in this herb as it has been promoted as a sweetening alternative to sucrose, beneficial specifically for those with obesity and diabetes. \u003ci\u003eStevia rebaudiana\u003c/i\u003e has little to no caloric value despite its sweetening abilities, thus will not jeopardise patients blood glucose levels, while fulfilling their cravings for sweet food and drinks [\u003ca href=\"#B4\"\u003e4\u003c/a\u003e]. \u003ci\u003eStevia rebaudiana\u003c/i\u003e is sweet due to its constituents of steviol glycosides including stevioside, rebaudioside A and rebaudioside C [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e]. Furthermore, previous reports showed this plant has antioxidant [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e] and antihyperglycaemic [\u003ca href=\"#B7\"\u003e7\u003c/a\u003e] properties, increasing its potential for use in adjuvant management of diabetes mellitus and associated conditions. There has been little investigation into such assertions which has prompted this study to evaluate how stevioside can affect insulin sensitivity, particularly through observation of glucose uptake, and expression of proteins involved in insulin-signalling pathway at a cellular level through use of 3T3-L1 adipocytes.\u003c/p\u003e\u003ch4 id=\"methods\"\u003e2. Methods\u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Materials\u003c/h5\u003e\u003cp\u003e\u0026#13;\n\t\t\t\t\t3T3-L1 preadipocytes were commercially acquired from ATCC (American Type Culture Collections, USA). Chemicals, including stevioside, cell supplements, and media, were mostly purchased from Sigma-Aldrich Co. (Germany) and Lonza (USA). Ultima Gold LLT scintillation cocktail and 2-deoxy-[1-3H]-glucose were commercially obtained from Perkin Elmer (USA). The antidiabetic drug rosiglitazone maleate (AVANDIA) was bought from a local drugstore. \u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e-Actin, p-IRS1, and pY20 primary antibodies, and donkey anti-goat and goat anti-rabbit horseradish peroxidase (HRP) conjugated secondary antibodies were purchased from Santa Cruz (USA).\u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. Cell Culture and Differentiation\u003c/h5\u003e\u003cp\u003e\u0026#13;\n\t\t\t\t\t3T3-L1 preadipocytes were cultured in Dulbeccos Modified Eagles Media (DMEM). Cells were later differentiated with supplements of insulin, dexamethasone (DMX), and 3-isobutyl-1-methyl-xanthine (IBMX) following the procedures described by Ahn et al. [\u003ca href=\"#B8\"\u003e8\u003c/a\u003e] and Ismail et al. [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e]. In order to induce insulin resistance, cells were treated with tumour necrosis factor-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e (TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e) at 1.0ng/mL for 4 days prior to treatment.\u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Oil Red-O Staining\u003c/h5\u003e\u003cp\u003e3T3-L1 cells were washed with phosphate-buffered saline (PBS) before being fixed with a solution of 10% formaldehyde in PBS. After overnight incubation, the solution was discarded and Oil Red-O dye was introduced to cells for 10 minutes at room temperature. Subsequently, excess dye was washed with de-ionised water. The stain was later eluted out with 100% isopropanol and measured spectrophotomerically at 520nm.\u003c/p\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. Cell Viability Test\u003c/h5\u003e\u003cp\u003e3T3-L1 adipocytes were cultured in 96-well plates and were pretreated with stevioside (25300\u003ci\u003e\u003c/i\u003eM) for 14, 24, 48, and 72 hours. After pretreatment, the cells received 5mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and were further incubated for 4 hours. The purple formazan crystals were then dissolved with dimethyl sulfoxide (DMSO) before their absorbance values were read on a microplate reader at 590nm.\u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Glucose Uptake Assay\u003c/h5\u003e\u003cp\u003eGlucose uptake levels by differentiated 3T3-L1 adipocytes were analysed using a method previously described by Adam et al. [\u003ca href=\"#B10\"\u003e10\u003c/a\u003e], with minor modifications. Briefly, 3T3-L1 adipocytes were differentiated on 12-well plates. For insulin-resistance studies, cells were initially induced to insulin resistance with TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e treatment, as mentioned earlier. Cells were serum-starved for 2 hours. Next, they were washed with Krebs-Ringer bicarbonate (KRB) buffer and preincubated with a range of stevioside concentrations (30150\u003ci\u003e\u003c/i\u003eM and 30120\u003ci\u003e\u003c/i\u003eM) for half an hour, with or without insulin addition, with rosiglitazone as a positive control. 2-Deoxy-[1-3H]-glucose (1\u003ci\u003e\u003c/i\u003eCi/mL) was then added to each well to initiate glucose uptake, and incubated for a further hour. Cells were then  washed with ice-cold KRB buffer and solubilised by 0.1% sodium dodecyl sulphate (SDS). Finally, samples were collected and mixed with 15mL of Ultima Gold LLT scintillation cocktail before being measured in a liquid scintillation counter.\u003c/p\u003e\u003ch5 id=\"sec2.6\"\u003e2.6. Western Blotting\u003c/h5\u003e\u003cp\u003e3T3-L1 cells were cultured and differentiated in 6-well plates. Cells were given TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e to induce insulin resistance, as described earlier, prior to treatment with stevioside. Treatments of stevioside and rosiglitazone maleate were given, in 60 and 90\u003ci\u003e\u003c/i\u003eM concentrations, for 24 hours. Cells were stimulated with insulin for 5 minutes prior to harvesting. From the preparation of cell lysates and loading of samples to Western blot analysis, procedures described by Ismail et al. [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e] were followed, with minor modifications.\u003c/p\u003e\u003ch5 id=\"sec2.7\"\u003e2.7. Statistical Analysis\u003c/h5\u003e\u003cp\u003eData were presented as mean  standard error mean (SEM) for a given number of tests. The results were processed statistically by one-way analysis of variance (ANOVA) followed by Dunnetts post-hoc tests, using the Sigma Plot version 12 software. Statistically different means were recognised at \u003csvg height=\"15.2875\" id=\"M3\" style=\"vertical-align:-3.50804pt;width:57.974998px;\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e.\u003c/p\u003e\u003ch4 id=\"results\"\u003e3. Results\u003c/h4\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Oil Red-O Staining\u003c/h5\u003e\u003cp\u003eEffects of the supplements (insulin, DMX, and IBMX) on adipocyte differentiation are presented in Figure \u003ca href=\"fig1/\" target=\"_blank\"\u003e1\u003c/a\u003e. In order to proceed with further experiments, adipocyte differentiation was confirmed by conducting the Oil Red-O staining procedure. Lipid stain from fully differentiated adipocytes was eluted out and measured quantitatively in a spectrophotometer, where the readings were found to be significantly increased when compared to control group.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig1\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"938081.fig.001\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.001.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of induction of differentiation on lipid accumulation in 3T3-L1 cells, presented by Oil Red-O staining. To quantify lipid accumulation in cells as a result of differentiation, the stain was eluted with 100% isopropanol and measured spectrophotometrically at 520nm. Mean  SEM (\u003csvg height=\"11.125\" id=\"M4\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.862)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.862)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). *Significantly different from control (\u003csvg height=\"15.2875\" id=\"M5\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ANOVA \u0026amp; Dunnetts test).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. MTT Cytotoxicity Test\u003c/h5\u003e\u003cp\u003eCells were previously differentiated to mature adipocytes before treatment with stevioside (25300\u003ci\u003e\u003c/i\u003eM) for 14, 24, 48, and 72 hours. Cell viability was determined from absorbance readings at 590nm, corresponding to formazan crystals formed by living cells (Figure \u003ca href=\"fig2/\" target=\"_blank\"\u003e2\u003c/a\u003e). There were no significant differences in cell viabilities in any of the stevioside treatment groups, at any treatment period, with the exception of those treated for a period of 72 hours. Viability of cells treated with 250\u003ci\u003e\u003c/i\u003eM of stevioside for 72 hours was reduced by 17% at most. No half-maximal inhibitory concentration (IC\u003csub\u003e50\u003c/sub\u003e) was found, as cell viability did not fall lower than the 80% benchmark.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig2\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig2\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.002c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.002d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig2\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.002c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.002d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.002d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig2\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 2\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig2/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eViability of 3T3-L1 adipocytes treated with stevioside for (a) 14 hours, (b) 24 hours, (c) 48 hours, and (d) 72 hours. Mean  SEM (\u003csvg height=\"11.075\" id=\"M6\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.075\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.8)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.8)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.8)\"\u003e\u003cpath d=\"M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z\" id=\"x34\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). Statistically significant compared to control (*\u003csvg height=\"15.2875\" id=\"M7\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, **\u003csvg height=\"15.2875\" id=\"M8\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, and ***\u003csvg height=\"15.2875\" id=\"M9\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ANOVA \u0026amp; Dunnetts test).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Glucose Uptake Assay\u003c/h5\u003e\u003ch6 id=\"sec3.3.1\"\u003e3.3.1. Optimum Insulin Concentration\u003c/h6\u003e\u003cp\u003ePrior to investigating effects of stevioside on glucose uptake in 3T3-L1 adipocytes, separate assays were conducted to find the optimum concentrations of insulin and TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e to be used. From Figure \u003ca href=\"fig3/#a\" target=\"_blank\"\u003e3(a)\u003c/a\u003e, it can be observed that starting from 100nM of insulin, there was a highly significant increase in glucose uptake, with maximum uptake at 125nM. There was no significant difference between these two groups. Therefore, 100nM insulin was selected as the optimum concentration to be used for further experiments.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig3\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig3\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig3\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig3\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 3\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig3/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eGlucose uptake in 3T3-L1 adipocytes exposed to (a) insulin and (b) TNF-\u003ci\u003e\u003c/i\u003e. Optimum insulin concentration to stimulate glucose uptake was 100nM, while optimum TNF-\u003ci\u003e\u003c/i\u003e concentration to reduce glucose uptake was 1.0ng/mL. Mean  SEM (\u003csvg height=\"11.075\" id=\"M10\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.075\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.8)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.8)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.8)\"\u003e\u003cpath d=\"M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z\" id=\"x34\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). Statistically significant compared to control (*\u003csvg height=\"15.2875\" id=\"M11\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, **\u003csvg height=\"15.2875\" id=\"M12\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ***\u003csvg height=\"15.2875\" id=\"M13\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ANOVA \u0026amp; Dunnetts test).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eA separate glucose uptake assay was conducted to find the optimum TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e concentration for inducing an insulin-resistant state in 3T3-L1 adipocytes. TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e reduced glucose uptake in the cells up to a concentration of 1.0ng/mL, beyond which there was an increase in glucose uptake at 2.5ng/mL (Figure \u003ca href=\"fig3/#b\" target=\"_blank\"\u003e3(b)\u003c/a\u003e). Since glucose uptake went down furthest at 1.0ng/mL, this concentration was selected as the optimum TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e concentration to induce insulin resistance in cells.\u003c/p\u003e\u003ch6 id=\"sec3.3.2\"\u003e3.3.2. Glucose Uptake in Normal 3T3-L1 Adipocytes\u003c/h6\u003e\u003cp\u003eGlucose uptake assay was next conducted on normal, non-insulin-resistant adipocytes to study effects of stevioside. Glucose uptake by adipocytes was increased by treatment with stevioside or with rosiglitazone (Figure \u003ca href=\"fig4/\" target=\"_blank\"\u003e4\u003c/a\u003e). Stevioside (30\u003ci\u003e\u003c/i\u003eM) elicited significant increase in glucose uptake, in both insulin-stimulated and non-insulin-stimulated groups. However, glucose uptake was higher in the insulin-stimulated group, by 2.1 times (\u003csvg height=\"15.2875\" id=\"M14\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) compared to control. This was better than what was observed in cells that were treated with rosiglitazone maleate, where glucose uptake in presence of insulin was increased by 1.7 times (\u003csvg height=\"15.2875\" id=\"M15\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) at a far higher concentration of 120\u003ci\u003e\u003c/i\u003eM.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig4\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig4\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.004c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.004d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig4\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.004c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.004d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.004d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig4\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 4\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig4/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of stevioside and rosiglitazone maleate on glucose uptake in normal 3T3-L1 adipocytes. (a) Treatment with stevioside or rosiglitazone maleate with insulin stimulation. (b) Treatment with stevioside or rosiglitazone maleate without insulin stimulation, (c) insulin-stimulated and non-insulin-stimulated groups treated with rosiglitazone maleate, and (d) insulin-stimulated and non-insulin-stimulated groups treated with stevioside. Mean  SEM (\u003csvg height=\"11.125\" id=\"M16\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.862)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.862)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). Statistically significant compared to control (***\u003csvg height=\"15.2875\" id=\"M17\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ANOVA \u0026amp; Dunnetts test).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch6 id=\"sec3.3.3\"\u003e3.3.3. Glucose Uptake in TNF-\u003ci\u003e\u003c/i\u003e Induced Adipocytes\u003c/h6\u003e\u003cp\u003e3T3-L1 cells were induced to insulin resistance using TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e, to test whether stevioside could exert similar effects on these cells as on normal adipocytes in terms of enhancing glucose uptake. Cells were pretreated with TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e prior to stevioside treatment and their glucose uptake was measured. In insulin-resistant adipocytes, stevioside was still able to stimulate glucose uptake although at a higher concentration of 90\u003ci\u003e\u003c/i\u003eM compared to the previous 30\u003ci\u003e\u003c/i\u003eM observed in normal adipocytes (Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e). Maximum increase in glucose uptake was observed in rosiglitazone-treated group (90\u003ci\u003e\u003c/i\u003eM) without insulin stimulation, with an elevation of up to 4.6 times (\u003csvg height=\"15.2875\" id=\"M18\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) when compared to control. This was followed by treatment with stevioside (90\u003ci\u003e\u003c/i\u003eM) with insulin stimulation, which elevated glucose uptake by 4.4-times (\u003csvg height=\"15.2875\" id=\"M19\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig5\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig5\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.005a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.005b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.005c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.005d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig5\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"938081.fig.005a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"938081.fig.005b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"938081.fig.005c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"938081.fig.005d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.005d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig5\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 5\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig5/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of stevioside and rosiglitazone maleate on glucose uptake in TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e induced insulin-resistant 3T3-L1 adipocytes. (a) Treatment with stevioside or rosiglitazone maleate with insulin stimulation. (b) Treatment with stevioside or rosiglitazone maleate without insulin stimulation, (c) insulin-stimulated and non-insulin-stimulated groups treated with rosiglitazone maleate, and (d) insulin-stimulated and non-insulin-stimulated groups treated with stevioside. Mean  SEM (\u003csvg height=\"11.125\" id=\"M20\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.862)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.862)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). Statistically significant compared to control (*\u003csvg height=\"15.2875\" id=\"M21\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, **\u003csvg height=\"15.2875\" id=\"M22\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ***\u003csvg height=\"15.2875\" id=\"M23\" style=\"vertical-align:-3.50804pt\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M570 304q0 -108 -87 -199q-40 -42 -94.5 -74t-105.5 -43q-41 0 -65 11l-29 -141q-9 -45 -1.5 -58t45.5 -16l26 -2l-5 -29l-241 -10l4 26q51 10 67.5 24t26.5 60l113 520q-54 -20 -89 -41l-7 26q38 28 105 53l11 49q20 25 77 58l8 -7l-17 -77q39 14 102 14q82 0 119 -36\u0026#10;t37 -108zM482 289q0 114 -113 114q-26 0 -66 -7l-70 -327q12 -14 32 -25t39 -11q59 0 118.5 81.5t59.5 174.5z\" id=\"x1D45D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e, ANOVA \u0026amp; Dunnetts test). RM: rosiglitazone maleate, Svs: stevioside.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch6 id=\"sec3.3.4\"\u003e3.3.4. Western Blotting\u003c/h6\u003e\u003cp\u003eIn this study, expressions of two proteins (p-IRS1 and pY20) that are essential to the insulin-signalling pathway were measured by Western blotting technique. Both proteins were poorly expressed or not expressed at all in the insulin-resistant control group (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). Treatment with stevioside led to expression of both proteins while treatment with rosiglitazone elicited an increase in expression of pY20, though the effects of both treatments were hardly distinguishable from those observed in normal, non-insulin-resistant cells.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig6\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig6\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"938081.fig.006\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2013/938081/figures/938081.fig.006.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 6\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig6/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eBand intensities observed via Western blotting, showing the different expression levels of phosphorylated insulin receptor substrate 1 (p-IRS1) and phosphorylated tyrosine (pY20), in groups treated with stevioside (Svs) and rosiglitazone maleate (RM) in comparison to the normal and insulin-resistant (IR) groups. \u003ci\u003e\u003ci\u003e\u003c/i\u003e-\u003c/i\u003eactin was used as a loading control. The experiment was repeated thrice.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch4 id=\"discussion\"\u003e4. Discussion\u003c/h4\u003e\u003cp\u003eAim of this study was to investigate effects of stevioside on insulin sensitivity of 3T3-L1 cells. Oil Red-O is a common lipid stain used to colour lipid droplets \u003ci\u003ein vitro\u003c/i\u003e, for quantification and for microscopic and imaging purposes. This specific staining method was used here to determine the degree to which adipocyte differentiation process (also called adipogenesis) had progressed since droplets secreted by adipocytes upon full differentiation to mature adipocytes will be stained (also referred to as lipid positive) [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e]. Microscopic observation also revealed that lipid droplets were present in cytoplasm of fully differentiated adipocytes in abundance, compared to their absence in preadipocytes before the differentiation process.\u003c/p\u003e\u003cp\u003eAs confirmation, there was a significant increase in absorbance values of eluted Oil Red-O stains from mature differentiated adipocytes (Figure \u003ca href=\"fig1/\" target=\"_blank\"\u003e1\u003c/a\u003e). The stains from mature adipocytes were increased by 2.4 times (\u003csvg height=\"15.2875\" id=\"M24\" style=\"vertical-align:-3.50804pt;width:57.974998px;\" version=\"1.1\" viewbox=\"0 0 57.974998 15.2875\" width=\"57.974998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) when compared to control, which was the stain from empty wells; and were 4.2 times (\u003csvg height=\"15.2875\" id=\"M25\" style=\"vertical-align:-3.50804pt;width:66.137497px;\" version=\"1.1\" viewbox=\"0 0 66.137497 15.2875\" width=\"66.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#x1D45D\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,14.851,10.862)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,29.555,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,37.715,10.862)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,41.59,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,49.75,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,57.909,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) higher when compared to preadipocytes. This showed that the insulin-DMX-IBMX supplements combination was successful at hormonally triggering adipocyte differentiation in cells, most possibly via activation of peroxisome proliferator activator receptor \u003ci\u003e\u003c/i\u003e (PPAR\u003ci\u003e\u003c/i\u003e) and CCAAT/enhancer binding protein \u003ci\u003e\u003c/i\u003e (C/EBP\u003ci\u003e\u003c/i\u003e), as reported by Jin et al. [\u003ca href=\"#B12\"\u003e12\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eFully differentiated 3T3-L1 adipocytes were then subjected to MTT assay to determine effect of stevioside on cell morphology and viability. 3T3-L1 Cells were treated with stevioside at concentrations ranging from 25 to 300\u003ci\u003e\u003c/i\u003eM, for several different treatment periods: 14, 24, 48, and 72 hours. Treatment for 14 hours was done as it was the stipulated doubling time for 3T3-L1 adipocytes [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e]. Viability of cells was not markedly altered by exposure to stevioside except at concentrations greater than 100\u003ci\u003e\u003c/i\u003eM following incubation for 72 hours. Even then cell viability was still higher than 80% with a maximum decrease of only 17%. Thus, median inhibitory concentration (IC\u003csub\u003e50\u003c/sub\u003e) could not be estimated from this study. Some slight, nonsignificant increase in cell viability of 3T3-L1 adipocytes was observed as has been previously reported [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e, \u003ca href=\"#B14\"\u003e14\u003c/a\u003e, \u003ca href=\"#B15\"\u003e15\u003c/a\u003e]. It can be surmised that stevioside did not exert cytotoxicity on 3T3-L1 adipocytes.\u003c/p\u003e\u003cp\u003eTo test effects of stevioside on insulin-sensitivity of 3T3-L1 adipocytes, its effects on glucose uptake by the adipocytes was determined. Radioactively labelled glucose uptake assays were conducted with use of antidiabetic agent, rosiglitazone as a positive control, as previously reported [\u003ca href=\"#B10\"\u003e10\u003c/a\u003e].\u003c/p\u003e\u003cp\u003ePrior to subjecting 3T3-L1 adipocytes to stevioside, response of the cells to insulin and to TNF-\u003ci\u003e\u003c/i\u003e were determined in separate assays to estimate optimum concentrations. These studies showed that glucose uptake was elevated with increase in insulin concentration in concentration-dependent manner reaching a plateau at 100nM of insulin. This insulin concentration was taken as  the optimum concentration for use in further glucose uptake assays using 3T3-L1 adipocytes as previously reported [\u003ca href=\"#B16\"\u003e16\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eTNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e has been implicated in the progression of insulin resistance; it disrupts phosphorylation of several proteins involved in insulin-signalling pathway, including IRS1, tyrosine, and most importantly, the downregulation of glucose transporter 4 (GLUT4) [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e, \u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e is also implicated in a number of catabolic states linked to insulin resistance such as sepsis and cancer even though its exact mechanism of actions remains unclear [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eTNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e caused a maximal decrease in glucose uptake at 1ng/mL, beyond which glucose uptake was increased when compared to control. This observation contradicted initial expectation of a concentration-dependent decrease in glucose uptake by TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e, as was previously reported [\u003ca href=\"#B19\"\u003e19\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eNormally differentiated, mature 3T3-L1 adipocytes which were not exposed to TNF-\u003ci\u003e\u003ci\u003e\u003c/i\u003e\u003c/i\u003e were used to evaluate effect of stevioside on insulin sensitivity in normal, non-insulin-resistant state to ascertain effects of its usage in health. Our data showed that stevioside was better than the positive control, rosiglitazone, at increasing glucose uptake in normal adipocytes. Glucose uptake was maximally increased by 30\u003ci\u003e\u003c/i\u003eM of stevioside, both in presence or in absence of insulin stimulation, surpassing that of rosiglitazone at 120\u003ci\u003e\u003c/i\u003eM.\u003c/p\u003e\u003cp\u003eIn TNF-\u003ci\u003e\u003c/i\u003e induced insulin resistance, glucose uptake was maximally increased by rosiglitazone or insulin at 90\u003ci\u003e\u003c/i\u003eM either in presence or absence of insulin. Since effect of rosiglitazone on glucose uptake was not different from that of stevioside, it may be concluded that both treaments were equally effective at enhancing glucose uptake in insulin-resistant cells.\u003c/p\u003e\u003cp\u003eThere appeared to be interaction between rosiglitazone and insulin in the insulin-resistant state with regards to glucose-uptake, which was lower in presence of 100nM insulin compared to in its absence. This observation was not seen with stevioside as presence of insulin further elevated glucose uptake compared to its absence. A similar trend of enhanced glucose uptake by stevioside and rosiglitazone was  observed in normal adipocytes. It may be assumed that steviosides interaction with insulin was unaffected by insulin resistance unlike that of rosiglitazone except higher concentration of stevioside was needed to elicit significant increase in glucose uptake during insulin-resistant state compared to normal state.  The different behaviour of insulin-stimulated versus non-insulin stimulated  cells to rosiglitazone has important bearing in hyperinsulinaemic states which often occur in insulin resistance, though not always. It is possible that stevioside is suitable for use in hyperinsulinaemic states, which, besides  diabetes, often occur in certain cancers [\u003ca href=\"#B20\"\u003e20\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eThis study investigated two proteinsthe phosphorylated insulin receptor substrate 1 (p-IRS1), and phosphorylated tyrosine (pY20) that act upstream of the insulin-signalling pathway. Our data showed  both proteins were poorly expressed or not expressed at all in insulin-resistant control group, which imply disruptions in the insulin-signalling pathway as previously reported by Solomon et al. [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. Such disruptions were successfully counteracted by stevioside which restored expression of both proteins, while rosiglitazone was also seen to increased expression of pY20 in insulin-resistant cells. Expression of pY20 was elevated  by treatment with rosiglitazone or stevioside (60\u003ci\u003e\u003c/i\u003eM \u0026amp; 90\u003ci\u003e\u003c/i\u003eM) which provided support for potential ability of stevioside at sensitising cells to insulin signalling. p-IRS1  expression was observed in normal cells and in those treated with stevioside, although the bands  were of  low resolutions and intensities. No  p-IRS1 bands were observed in insulin-resistant cells, including those treated with rosiglitazone. This showed that stevioside was able to restore p-IRS1 expressions, similar to those observed in normal group. Stevioside possibly have an effect upstream of the insulin-signalling pathway, by elevating levels of pY20 and probably p-IRS1 as well, which will result in GLUT4 translocation to increase uptake of extracellular glucose. Antihyperglycemic effects of stevioside on cell metabolism as a whole has also been previously reported [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e].\u003c/p\u003e\u003ch4 id=\"conclusion\"\u003e5. Conclusion\u003c/h4\u003e\u003cp\u003eStevioside proved to be as effective as the antidiabetic agent, rosiglitazone, at enhancing glucose uptake in normal 3T3-L1 adipocytes or in cells induced to insulin resistance via exposure to TNF-\u003ci\u003e\u003c/i\u003e. In normal adipocytes, stevioside at a concentration that was a quarter that of rosiglitazone produced greater increase in glucose uptake than the antidiabetic agent, both in absence or presence of insulin-stimulation. In insulin-resistant cells, stevioside was as effective as rosiglitazone as similar concentrations of both produced comparable stimulation of glucose uptake in absence or presence of insulin. Enhancement of glucose uptake by stevioside was accompanied by increased expression  of p-IRS1 and pY20, denoting involvement of GLUT-4 translocation. Further studies are needed to unravel mechanisms underlying use of stevioside in adjuvant management of diabetes mellitus and its associated complications.\u003c/p\u003e\u003ch4 id=\"acknowledgments\"\u003eAcknowledgments\u003c/h4\u003e\u003cp\u003eThis research was funded by the Fundamental Research Grant Scheme (FRGS) 600-RMI/ST/FRGS 5/3 Fst (52/2011) under Universiti Teknologi MARA and provided by the Ministry of Higher Education, Malaysia.\u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eJ.-P. Bastard, M. Maachi, C. Lagathu et al., Recent advances in the relationship between obesity, inflammation, and insulin resistance, \u003ci\u003eEuropean Cytokine Network\u003c/i\u003e, vol. 17, no. 1, pp. 412, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20the%20relationship%20between%20obesity,%20inflammation,%20and%20insulin%20resistance\u0026author=J.-P. Bastard\u0026author=M. Maachi\u0026author=C. Lagathu et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eN. Houstis, E. D. Rosen, and E. S. Lander, Reactive oxygen species have a causal role in multiple forms of insulin resistance, \u003ci\u003eNature\u003c/i\u003e, vol. 440, no. 7086, pp. 944948, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nature04634\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Reactive%20oxygen%20species%20have%20a%20causal%20role%20in%20multiple%20forms%20of%20insulin%20resistance\u0026author=N. Houstis\u0026author=E. D. Rosen\u0026author=\u0026author=E. S. Lander\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eB. B. Kahn and J. S. Flier, Obesity and insulin resistance, \u003ci\u003eJournal of Clinical Investigation\u003c/i\u003e, vol. 106, no. 4, pp. 473481, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Obesity%20and%20insulin%20resistance\u0026author=B. B. Kahn \u0026author=J. S. Flier\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eS. D. Anton, C. K. Martin, H. Han et al., Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels, \u003ci\u003eAppetite\u003c/i\u003e, vol. 55, no. 1, pp. 3743, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.appet.2010.03.009\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effects%20of%20stevia,%20aspartame,%20and%20sucrose%20on%20food%20intake,%20satiety,%20and%20postprandial%20glucose%20and%20insulin%20levels\u0026author=S. D. Anton\u0026author=C. K. Martin\u0026author=H. Han et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003eG. Brahmachari, L. C. Mandal, R. Roy, S. Mondal, and A. K. Brahmachari, Stevioside and related compounds\u0026#x2014;molecules of pharmaceutical promise: a critical overview, \u003ci\u003eArchiv der Pharmazie\u003c/i\u003e, vol. 344, no. 1, pp. 519, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ardp.201000181\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Stevioside%20and%20related%20compoundsmolecules%20of%20pharmaceutical%20promise:%20a%20critical%20overview\u0026author=G. Brahmachari\u0026author=L. C. Mandal\u0026author=R. Roy\u0026author=S. Mondal\u0026author=\u0026author=A. K. Brahmachari\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eI.-S. Kim, M. Yang, O.-H. Lee, and S.-N. Kang, The antioxidant activity and the bioactive compound content of \u003ci\u003eStevia rebaudiana\u003c/i\u003e water extracts, \u003ci\u003eFood Science and Technology\u003c/i\u003e, vol. 44, no. 5, pp. 13281332, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.lwt.2010.12.003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20antioxidant%20activity%20and%20the%20bioactive%20compound%20content%20of%20Stevia%20rebaudiana%20water%20extracts\u0026author=I.-S. Kim\u0026author=M. Yang\u0026author=O.-H. Lee\u0026author=\u0026author=S.-N. Kang\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eS. K. Yadav and P. Guleria, Steviol glycosides from stevia: biosynthesis pathway review and their application in foods and medicine, \u003ci\u003eCritical Reviews in Food Science and Nutrition\u003c/i\u003e, vol. 52, no. 11, pp. 988998, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1080/10408398.2010.519447\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Steviol%20glycosides%20from%20stevia:%20biosynthesis%20pathway%20review%20and%20their%20application%20in%20foods%20and%20medicine\u0026author=S. K. Yadav \u0026author=P. Guleria\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eM.-Y. Ahn, K. D. Katsanakis, F. Bheda, and T. S. Pillay, Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 279, no. 20, pp. 2152621532, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M307740200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Primary%20and%20essential%20role%20of%20the%20adaptor%20protein%20APS%20for%20recruitment%20of%20both%20c-Cbl%20and%20its%20associated%20protein%20CAP%20in%20insulin%20signaling\u0026author=M.-Y. Ahn\u0026author=K. D. Katsanakis\u0026author=F. Bheda\u0026author=\u0026author=T. S. Pillay\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eW. I. W. Ismail, J. A. King, K. Anwar, and T. S. Pillay, Indinavir and nelfinavir inhibit proximal insulin receptor signalling and salicylate abrogates inhibition: potential role of NF\u003cmath id=\"M26\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmi\u003e\u0026#x3ba;\u003c/mi\u003e\u003c/mrow\u003e\u003c/math\u003eB pathway, \u003ci\u003eJournal of Cellular Biochemistry\u003c/i\u003e, vol. 9999, pp. 110, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Indinavir%20and%20nelfinavir%20inhibit%20proximal%20insulin%20receptor%20signalling%20and%20salicylate%20abrogates%20inhibition:%20potential%20role%20of%20NFB%20pathway\u0026author=W. I. W. Ismail\u0026author=J. A. King\u0026author=K. Anwar\u0026author=\u0026author=T. S. Pillay\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eZ. Adam, S. Khamis, A. Ismail, and M. Hamid, \u003ci\u003eFicus deltoidea\u003c/i\u003e: a potential alternative medicine for diabetes mellitus, \u003ci\u003eEvidence-Based Complementary and Alternative Medicine\u003c/i\u003e, vol. 2012, Article ID 632763, 12 pages, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1155/2012/632763\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Ficus%20deltoidea:%20a%20potential%20alternative%20medicine%20for%20diabetes%20mellitus\u0026author=Z. Adam\u0026author=S. Khamis\u0026author=A. Ismail\u0026author=\u0026author=M. Hamid\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eH. Masuno, S. Okamoto, J. Iwanami et al., Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells, \u003ci\u003eToxicological Sciences\u003c/i\u003e, vol. 75, no. 2, pp. 314320, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/toxsci/kfg203\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effect%20of%204-nonylphenol%20on%20cell%20proliferation%20and%20adipocyte%20formation%20in%20cultures%20of%20fully%20differentiated%203T3-L1%20cells\u0026author=H. Masuno\u0026author=S. Okamoto\u0026author=J. Iwanami et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eL. Jin, W. Fang, B. Li et al., Inhibitory effect of Andrographolide in 3T3-L1 adipocytes differentiation through the PPAR\u003ci\u003e\u0026#x3b3;\u003c/i\u003e pathway, \u003ci\u003eMolecular and Cellular Endocrinology\u003c/i\u003e, vol. 358, no. 1, pp. 8187, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.mce.2012.02.025\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibitory%20effect%20of%20Andrographolide%20in%203T3-L1%20adipocytes%20differentiation%20through%20the%20PPAR%20pathway\u0026author=L. Jin\u0026author=W. Fang\u0026author=B. Li et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eZ. Qiu, Y. Wei, N. Chen, M. Jiang, J. Wu, and K. Liao, DNA synthesis and mitotic clonal expansion is not required for 3T3-L1 preadipocyte differentiation into adipocytes, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 276, no. 15, pp. 1198811995, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M011729200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=DNA%20synthesis%20and%20mitotic%20clonal%20expansion%20is%20not%20required%20for%203T3-L1%20preadipocyte%20differentiation%20into%20adipocytes\u0026author=Z. Qiu\u0026author=Y. Wei\u0026author=N. Chen\u0026author=M. Jiang\u0026author=J. Wu\u0026author=\u0026author=K. Liao\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eM. Nagayama, T. Uchida, and K. Gohara, Temporal and spatial variations of lipid droplets during adipocyte division and differentiation, \u003ci\u003eJournal of Lipid Research\u003c/i\u003e, vol. 48, no. 1, pp. 918, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1194/jlr.M600155-JLR200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Temporal%20and%20spatial%20variations%20of%20lipid%20droplets%20during%20adipocyte%20division%20and%20differentiation\u0026author=M. Nagayama\u0026author=T. Uchida\u0026author=\u0026author=K. Gohara\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eX. Wang, H. Liu, L. Zhao et al., Effects of crude polysaccharides from \u003ci\u003eCatathelasma venticosum\u003c/i\u003e on the proliferation and differentiation of 3T3-L1 cells, \u003ci\u003eAgricultural Journal\u003c/i\u003e, vol. 7, no. 3, pp. 187190, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3923/aj.2012.187.190\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effects%20of%20crude%20polysaccharides%20from%20Catathelasma%20venticosum%20on%20the%20proliferation%20and%20differentiation%20of%203T3-L1%20cells\u0026author=X. Wang\u0026author=H. Liu\u0026author=L. Zhao et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eH. Ruan, N. Hacohen, T. R. Golub, L. van Parijs, and H. F. Lodish, Tumor necrosis factor-\u003ci\u003e\u0026#x3b1;\u003c/i\u003e suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB activation by TNF-\u003ci\u003e\u0026#x3b1;\u003c/i\u003e is obligatory, \u003ci\u003eDiabetes\u003c/i\u003e, vol. 51, no. 5, pp. 13191336, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Tumor%20necrosis%20factor-%20suppresses%20adipocyte-specific%20genes%20and%20activates%20expression%20of%20preadipocyte%20genes%20in%203T3-L1%20adipocytes:%20nuclear%20factor-B%20activation%20by%20TNF-%20is%20obligatory\u0026author=H. Ruan\u0026author=N. Hacohen\u0026author=T. R. Golub\u0026author=L. van Parijs\u0026author=\u0026author=H. F. Lodish\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003eS. S. Solomon, S. K. Mishra, M. R. Palazzolo, A. E. Postlethwaite, and J. M. Seyer, Identification of specific sites in the TNF-\u003ci\u003e\u0026#x3b1;\u003c/i\u003e molecule promoting insulin resistance in H-411E cells, \u003ci\u003eThe Journal of Laboratory and Clinical Medicine\u003c/i\u003e, vol. 130, no. 2, pp. 139146, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Identification%20of%20specific%20sites%20in%20the%20TNF-%20molecule%20promoting%20insulin%20resistance%20in%20H-411E%20cells\u0026author=S. S. Solomon\u0026author=S. K. Mishra\u0026author=M. R. Palazzolo\u0026author=A. E. Postlethwaite\u0026author=\u0026author=J. M. Seyer\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eJ. K. Sethi and G. S. Hotamisligil, The role of TNF\u003ci\u003e\u0026#x3b1;\u003c/i\u003e in adipocyte metabolism, \u003ci\u003eSeminars in Cell and Developmental Biology\u003c/i\u003e, vol. 10, no. 1, pp. 1929, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20role%20of%20TNF%20in%20adipocyte%20metabolism\u0026author=J. K. Sethi \u0026author=G. S. Hotamisligil\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eG. S. Hotamisligil, D. L. Murray, L. N. Choy, and B. M. Spiegelman, Tumor necrosis factor \u003ci\u003e\u0026#x3b1;\u003c/i\u003e inhibits signaling from the insulin receptor, \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 91, no. 11, pp. 48544858, 1994. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.91.11.4854\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Tumor%20necrosis%20factor%20%20inhibits%20signaling%20from%20the%20insulin%20receptor\u0026author=G. S. Hotamisligil\u0026author=D. L. Murray\u0026author=L. N. Choy\u0026author=\u0026author=B. M. Spiegelman\u0026publication_year=1994\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eD. H. Cohen and D. LeRoith, Obesity, type 2 diabetes, and cancer: the insulin and IGF connection, \u003ci\u003eEndocrine-Related Cancer\u003c/i\u003e, vol. 19, pp. F27F45, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1530/ERC-11-0374\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Obesity,%20type%202%20diabetes,%20and%20cancer:%20the%20insulin%20and%20IGF%20connection\u0026author=D. H. Cohen \u0026author=D. LeRoith\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eS. Gregersen, P. B. Jeppesen, J. J. Holst, and K. Hermansen, Antihyperglycemic effects of stevioside in type 2 diabetic subjects, \u003ci\u003eMetabolism\u003c/i\u003e, vol. 53, no. 1, pp. 7376, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.metabol.2003.07.013\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antihyperglycemic%20effects%20of%20stevioside%20in%20type%202%20diabetic%20subjects\u0026author=S. Gregersen\u0026author=P. B. Jeppesen\u0026author=J. J. Holst\u0026author=\u0026author=K. Hermansen\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright \u0026#xa9; 2013 Nabilatul Hani Mohd-Radzman et al. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"methods","title":"Methods"},{"hash":"results","title":"Results"},{"hash":"discussion","title":"Discussion"},{"hash":"conclusion","title":"Conclusion"},{"hash":"acknowledgments","title":"Acknowledgments"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/ecam/2013/938081.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/ecam/2013/938081.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/ecam/2013/938081.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/ecam/2013/938081.xml"}]}],"articleStats":{"no_of_views":3937,"no_of_downloads":1716,"no_of_citations":14},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":[],"MODERATE":[],"LOW":["A \u003cb\u003eCorrigendum\u003c/b\u003e for this article has been published.\n  To view the article details, please click the Corrigendum tab above."]}},"year":"2013","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/ecam/2013/938081/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/ecam/2013/938081/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"cpr9K8AjZYaP4CWVbtn5c","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js"></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" async=""></script><script src="https://www.hindawi.com/static/themes/hindawi/base.js"></script></body></html>